| The effect of high dietary fiber intake on gestational weight gain, fat accrual, and postpartum weight retention: a randomized clinical trial 2020 · Single goal (SG) intervention · Pregnant women aged 18–45 years, singleton pregnancy, BMI 22–40 kg/m², recruited at 10–14 weeks’ gestation | 30 g | 12 weeks | 16 |
| Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth 2010 · rifaximin plus partially hydrolysed guar gum · Patients with small intestinal bacterial overgrowth (SIBO) and predisposing conditions to SIBO | 5 g | 10 days | — |
| One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept study 2013 · Rifaximin plus fibre · Patients with a recent episode of colonic diverticulitis, currently in remission | 7 g | 1 year | — |
| One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept study 2013 · Fibre supplementation alone · Patients with a recent episode of colonic diverticulitis, currently in remission | 7 g | 1 year | — |
| The role of dietary fiber on preventing gestational diabetes mellitus in an at-risk group of high triglyceride-glucose index women: a randomized controlled trial 2023 · fiber group · Pregnant women with a TyG index ≥8.5 before 20 weeks of gestation | 24 g | 5 weeks | — |
| Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas 1995 · Wheat bran intervention (with or without low-fat intervention) · Adults with at least one histologically confirmed colorectal adenoma that had been removed | 25 g | 1461 days | — |
| Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas 1995 · Wheat bran plus low-fat intervention · Adults with at least one histologically confirmed colorectal adenoma that had been removed | 25 g | 1461 days | — |
| The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial 2025 · HAMSB (butyrylated high-amylose maize starch) · People with medically diagnosed familial adenomatous polyposis (FAP), ages 12 years and older; men and women; with a history of polyp detection | 40 g | 26 weeks | — |
| Metabolite Biomarkers Linking a High-Fiber Rye Intervention with Cardiometabolic Risk Factors: The RyeWeight Study 2025 · rye group · Men and women aged 30–70 years with overweight or obesity (BMI 27–35 kg/m²) | 30 g | 12 weeks | 108 |
| Metabolite Biomarkers Linking a High-Fiber Rye Intervention with Cardiometabolic Risk Factors: The RyeWeight Study 2025 · refined wheat group · Men and women aged 30–70 years with overweight or obesity (BMI 27–35 kg/m²) | 8 g | 12 weeks | 99 |
| Sugarcane bagasse dietary fiber as an adjuvant therapy for stable chronic obstructive pulmonary disease: a four-center, randomized, double-blind, placebo-controlled study 2016 · trial group · Patients with stable chronic obstructive pulmonary disease; age and sex not stated | 6 g | 30 days | 98 |
| Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial 2009 · Bran · Adults aged 18-65 with irritable bowel syndrome | 10 g | 12 weeks | 97 |
| Benefits of Fiber-Enriched Foods on Satiety and Parameters of Human Well-Being in Adults with and without Cardiometabolic Risk 2023 · intervention group · Adults with normal weight or elevated waist circumference indicating elevated cardiometabolic risk | 10 g | 12 weeks | 74 |
| A natural fiber complex reduces body weight in the overweight and obese: a double-blind, randomized, placebo-controlled study 2013 · IQP G-002AS group (IQ) · Men and women aged 18–60 years with overweight or obesity (BMI 25–35) | 1.5 g | 12 weeks | 62 |
| [The efficacy and safety of testa triticum tricum purif in treatment of functional constipation in the late middle-aged and elderly patients: a multicenter randomized controlled clinical trial] 2017 · testa triticum tricum purif group · Adults aged 55–85 with functional constipation | 7 g | 12 weeks | 62 |
| Effects of NUTRIOSE® dietary fiber supplementation on body weight, body composition, energy intake, and hunger in overweight men 2011 · Test · Overweight Chinese men | 34 g | 12 weeks | 60 |
| Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation 1998 · Group 2 · Adults aged 18–50 with chronic functional constipation | 25 g | 60 days | 59 |
| Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation 1998 · Group 1 · Adults aged 18–50 with chronic functional constipation | 25 g | 60 days | 58 |
| Dietary fiber supplementation for fecal incontinence: a randomized clinical trial 2014 · CMC group · Community-living adults aged 18 or older with fecal incontinence of loose or liquid feces | 16.2 g | 38 days | 53 |
| Dietary fiber supplementation for fecal incontinence: a randomized clinical trial 2014 · GA group · Community-living adults aged 18 or older with fecal incontinence of loose or liquid feces | 16.6 g | 38 days | 50 |
| Symptoms associated with dietary fiber supplementation over time in individuals with fecal incontinence 2011 · gum arabic group · Community-living adults aged 18 or older with fecal incontinence; predominantly middle-aged and female | 17.3 g | 52 days | 49 |
| Impact of resistant starch type 3 on fecal microbiota and stool frequency in Thai adults with chronic constipation randomized clinical trial 2024 · RS-3 · Thai adults aged 20–60 with self-reported chronic constipation meeting Rome IV criteria | 9 g | 12 weeks | 49 |
| The Effect of Soluble Fiber Dextrin on Subjective and Physiological Markers of Appetite: A Randomized Trial 2020 · Corn10 · Healthy adults aged 18–45 years with BMI 19.9–29.9 kg/m² | 20 g | 1 day | 48 |
| The Effect of Soluble Fiber Dextrin on Subjective and Physiological Markers of Appetite: A Randomized Trial 2020 · Corn20 · Healthy adults aged 18–45 years with BMI 19.9–29.9 kg/m² | 40 g | 1 day | 48 |
| The Effect of Soluble Fiber Dextrin on Subjective and Physiological Markers of Appetite: A Randomized Trial 2020 · Tapioca10 · Healthy adults aged 18–45 years with BMI 19.9–29.9 kg/m² | 20 g | 1 day | 48 |
| The Effect of Soluble Fiber Dextrin on Subjective and Physiological Markers of Appetite: A Randomized Trial 2020 · Tapioca20 · Healthy adults aged 18–45 years with BMI 19.9–29.9 kg/m² | 40 g | 1 day | 48 |
| Symptoms associated with dietary fiber supplementation over time in individuals with fecal incontinence 2011 · CMC group · Community-living adults aged 18 or older with fecal incontinence; predominantly middle-aged and female | 21.5 g | 52 days | 47 |
| Treatment effects of partially hydrolyzed guar gum on symptoms and quality of life of patients with irritable bowel syndrome. A multicenter randomized open trial 2005 · 5 g/day PHGG group · Patients with irritable bowel syndrome; age and sex not specified | 5 g | 12 weeks | 46 |
| [Efficacy of pectin in the treatment of diarrhea predominant irritable bowel syndrome] 2015 · pectin powder · Patients with diarrhea-predominant irritable bowel syndrome (IBS-D) | 24 g | 6 weeks | 46 |
| Effect of High Fiber Cereal Intake on Satiety and Gastrointestinal Symptoms during Ramadan 2019 · intervention group · Adults aged 18–47, mostly women, without reported chronic disease, fasting during Ramadan; UAE university students and staff | 11 g | 20 days | 45 |
| Treatment effects of partially hydrolyzed guar gum on symptoms and quality of life of patients with irritable bowel syndrome. A multicenter randomized open trial 2005 · 10 g/day PHGG group · Patients with irritable bowel syndrome; age and sex not specified | 10 g | 12 weeks | 40 |
| Randomised clinical trial: mixed soluble/insoluble fibre vs. psyllium for chronic constipation 2016 · mixed fiber · Adults aged 18–75 with chronic constipation | 10 g | 4 weeks | 40 |
| Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota 2024 · resistant starch (HAM-RS2) · Adults aged 18–55 years with excess body weight, defined by BMI ≥24 kg/m² or increased waist circumference; no chronic disorders reported | 40 g | 8 weeks | 37 |
| Effects of two dietary fibers as part of ready-to-eat cereal (RTEC) breakfasts on perceived appetite and gut hormones in overweight women 2015 · HF-AXOS RTEC (trial 2) · Overweight women aged 18–29 years with BMI 25.0–29.9 | 15 g | 1 day | 36 |
| Effects of two dietary fibers as part of ready-to-eat cereal (RTEC) breakfasts on perceived appetite and gut hormones in overweight women 2015 · HF-FLAX RTEC (trial 2) · Overweight women aged 18–29 years with BMI 25.0–29.9 | 15 g | 1 day | 36 |
| Effect of Dietary Fiber (Oat Bran) Supplement in Heart Rate Lowering in Patients with Hypertension: A Randomized DASH-Diet-Controlled Clinical Trial 2022 · intervention (dietary fiber, DF) group · Adults aged 18–65 with stage 1 hypertension | 30 g | 90 days | 36 |
| Efficacy and safety of Gelidium elegans intake on bowel symptoms in obese adults: A 12-week randomized double-blind placebo-controlled trial 2019 · Gelidium elegans group · Adults aged 20 years or older with obesity (BMI 25–30 kg/m²) | 1 g | 12 weeks | 34 |
| The effects of probiotics plus dietary fiber on antipsychotic-induced weight gain: a randomized clinical trial 2022 · Dietary fiber · Adults aged 18–45 with schizophrenia or bipolar disorder, receiving atypical antipsychotics and with more than 10% weight gain | 60 g | 12 weeks | 34 |
| Digestion-resistant maltodextrin effects on colonic transit time and stool weight: a randomized controlled clinical study 2016 · RMD · Healthy adults aged 18–30 years, both sexes, with BMI below 30 kg/m² and no daily defecation habit or digestive disease | 15 g | 3 weeks | 33 |
| Satiety and energy intake after single and repeated exposure to gel-forming dietary fiber: post-ingestive effects 2014 · pectin · Adults aged 21±2 years, 24 women and 8 men, with BMI 21.8±1.9 kg/m² | 10 g | 15 days | 32 |
| Effects of native banana starch supplementation on body weight and insulin sensitivity in obese type 2 diabetics 2010 · Native banana starch (NBS) · Adults aged 40–60 with obesity (BMI >30) and type 2 diabetes | 24 g | 4 weeks | 30 |
| Partially hydrolyzed guar gum in pediatric functional abdominal pain 2013 · PHGG group · Children aged 8–16 years with functional bowel disorders, including chronic abdominal pain or irritable bowel syndrome | 5 g | 4 weeks | 30 |
| Effects of two dietary fibers as part of ready-to-eat cereal (RTEC) breakfasts on perceived appetite and gut hormones in overweight women 2015 · HF-AXOS RTEC (trial 1) · Overweight women aged 18–29 years with BMI 25.0–29.9 | 15 g | 1 day | 30 |
| Effects of two dietary fibers as part of ready-to-eat cereal (RTEC) breakfasts on perceived appetite and gut hormones in overweight women 2015 · HF-FLAX RTEC (trial 1) · Overweight women aged 18–29 years with BMI 25.0–29.9 | 15 g | 1 day | 30 |
| Acute effects of different dietary polysaccharides added in milk on food intake, postprandial appetite and glycemic responses in healthy young females 2016 · Carrageenan · Females aged 18–30 years; healthy | 2.5 g | 1 day | 30 |
| Acute effects of different dietary polysaccharides added in milk on food intake, postprandial appetite and glycemic responses in healthy young females 2016 · Guar gum · Females aged 18–30 years; healthy | 2.5 g | 1 day | 30 |
| Acute effects of different dietary polysaccharides added in milk on food intake, postprandial appetite and glycemic responses in healthy young females 2016 · Alginate · Females aged 18–30 years; healthy | 2.5 g | 1 day | 30 |
| Effect of Fiber-Rich Diet and Rope Skipping on Memory, Executive Function, and Gut Microbiota in Young Adults: A Randomized Controlled Trial 2024 · FD group · Undergraduates aged 19 ± 1 years | 20 g | 12 weeks | 30 |
| Effect of Fiber-Rich Diet and Rope Skipping on Memory, Executive Function, and Gut Microbiota in Young Adults: A Randomized Controlled Trial 2024 · FD-RS group · Undergraduates aged 19 ± 1 years | 20 g | 12 weeks | 30 |
| Fibermalt is well tolerated in healthy men and women at intakes up to 60 g/d: a randomized, double-blind, crossover trial 2013 · 45 g fibre · Healthy men and women | 45 g | 2 weeks | 29 |
| Fibermalt is well tolerated in healthy men and women at intakes up to 60 g/d: a randomized, double-blind, crossover trial 2013 · 60 g fibre · Healthy men and women | 60 g | 2 weeks | 29 |
| Sporulated Bacillus as alternative treatment for diarrhea of hospitalized adult patients under enteral nutrition: A pilot randomized controlled study 2017 · soluble fiber (control group) · Hospitalized adults with diarrhea receiving enteral nutrition and antibiotic therapy | 30 g | 5 days | 29 |
| Supplementation of the diet with the functional fiber PolyGlycoplex is well tolerated by healthy subjects in a clinical trial 2009 · PGX (study group) · Healthy men and women aged 18–55 | 10 g | 3 weeks | 27 |
| Effects of flax fiber on laxation and glycemic response in healthy volunteers 2005 · flax fiber supplement (Study 1) · Healthy young adults; age range and sex not stated | 9 g | 2 weeks | 26 |
| Effectiveness of Partially Hydrolyzed Guar Gum in Reducing Constipation in Long Term Care Facility Residents: A Randomized Single-Blinded Placebo-Controlled Trial 2022 · PHGG group · Long-term care facility residents aged 65 or older with constipation meeting Rome III criteria; men and women | 5 g | 4 weeks | 26 |
| Oral Supplementation with Algal Sulphated Polysaccharide in Subjects with Inflammatory Skin Conditions: A Randomised Double-Blind Placebo-Controlled Trial and Baseline Dietary Differences 2023 · Group AB: placebo for six weeks, then SXRG84 for six weeks · Adults with inflammatory skin conditions, including psoriasis, eczema, rosacea or dermatitis; most were overweight, with healthy-weight participants also included | 2 g | 6 weeks | 25 |
| Tolerance of high fibre supplementation among participants in a randomised trial to reduce cancer risk among Alaska Native peoples: Alaska FIRST 2025 · Intervention Group · Healthy Alaska Native adults aged 40–75 undergoing routine colorectal cancer screening | 70 g | 4 weeks | 25 |
| Flaxseed dietary fiber supplements for suppression of appetite and food intake 2012 · Flax drink (Study I) · Human subjects; age, sex and health condition not reported | 2.5 g | 1 day | 24 |
| Soluble Dietary Fiber Reduces Feeding Intolerance in Severe Acute Pancreatitis: A Randomized Study 2021 · SDF group · Patients with severe acute pancreatitis receiving enteral nutrition | 20 g | 4 weeks | 24 |
| A novel source of wheat fiber and protein: effects on fecal bulk and serum lipids 1999 · Test supplement · Healthy men and women; age and sex distribution not reported | 21 g | 2 weeks | 24 |
| A novel source of wheat fiber and protein: effects on fecal bulk and serum lipids 1999 · Positive control (American Association of Cereal Chemists wheat bran supplement) · Healthy men and women; age and sex distribution not reported | 21 g | 2 weeks | 24 |
| A novel source of wheat fiber and protein: effects on fecal bulk and serum lipids 1999 · Negative control supplement · Healthy men and women; age and sex distribution not reported | 1.7 g | 2 weeks | 24 |
| The effect of wheat bran particle size on laxation and colonic fermentation 1999 · Metabolic study, 50 microm mean particle size wheat bran · Healthy subjects; age and sex not stated | 19 g | — | 23 |
| The effect of wheat bran particle size on laxation and colonic fermentation 1999 · Metabolic study, 758 microm mean particle size wheat bran · Healthy subjects; age and sex not stated | 19 g | — | 23 |
| Effect of Repeated Consumption of Partially Hydrolyzed Guar Gum on Fecal Characteristics and Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled, and Parallel-Group Clinical Trial 2019 · PHGG group · Healthy Japanese men and women aged 20–49 with loose stools | 5 g | 12 weeks | 22 |
| Acute ingestion of resistant starch reduces food intake in healthy adults 2010 · resistant starch · Young healthy adult males | 48 g | 1 day | 20 |
| Acute effect of alginate-based preload on satiety feelings, energy intake, and gastric emptying rate in healthy subjects 2012 · low-volume alginate preload · Normal-weight adults; mean age 25.9 years; healthy subjects | 19.8 g | 1 day | 20 |
| Acute effect of alginate-based preload on satiety feelings, energy intake, and gastric emptying rate in healthy subjects 2012 · high-volume alginate preload · Normal-weight adults; mean age 25.9 years; healthy subjects | 30 g | 1 day | 20 |
| The soluble fiber NUTRIOSE induces a dose-dependent beneficial impact on satiety over time in humans 2011 · 8 g/d NUTRIOSE group · overweight healthy adults in China | 8 g | 3 weeks | 20 |
| The soluble fiber NUTRIOSE induces a dose-dependent beneficial impact on satiety over time in humans 2011 · 14 g/d NUTRIOSE group · overweight healthy adults in China | 14 g | 3 weeks | 20 |
| The soluble fiber NUTRIOSE induces a dose-dependent beneficial impact on satiety over time in humans 2011 · 18 g/d NUTRIOSE group · overweight healthy adults in China | 18 g | 3 weeks | 20 |
| The soluble fiber NUTRIOSE induces a dose-dependent beneficial impact on satiety over time in humans 2011 · 24 g/d NUTRIOSE group · overweight healthy adults in China | 24 g | 3 weeks | 20 |
| Flaxseed dietary fiber supplements for suppression of appetite and food intake 2012 · Flax drink (Study II) · Human subjects; age, sex and health condition not reported | 2.5 g | 1 day | 20 |
| Flaxseed dietary fiber supplements for suppression of appetite and food intake 2012 · Flax tablets (Study II) · Human subjects; age, sex and health condition not reported | 2.5 g | 1 day | 20 |
| Evaluation of digestive tolerance of a soluble corn fibre 2012 · SGF, acute single dose (40 g fibre) · Healthy volunteers; age and sex not specified | 40 g | — | 20 |
| Evaluation of digestive tolerance of a soluble corn fibre 2012 · SGF, spread over the day (65 g fibre) · Healthy volunteers; age and sex not specified | 65 g | — | 20 |
| The effect of yellow pea protein and fibre on short-term food intake, subjective appetite and glycaemic response in healthy young men 2012 · F10 (10 g yellow pea fibre) · Healthy men aged 20–30 years | 10 g | 1 day | 20 |
| The effect of yellow pea protein and fibre on short-term food intake, subjective appetite and glycaemic response in healthy young men 2012 · F20 (20 g yellow pea fibre) · Healthy men aged 20–30 years | 20 g | 1 day | 20 |
| Clinical studies in persistent diarrhea: dietary management with green banana or pectin in Bangladeshi children 2001 · pectin group · boys aged 5–12 months hospitalized with persistent diarrhea | 4,000 mg/kg | 7 days | 19 |
| Fibre in beverages can enhance perceived satiety 2009 · guar gum beverage · Healthy volunteers aged 18–30 years | 7.8 g | 1 day | 19 |
| Fibre in beverages can enhance perceived satiety 2009 · wheat bran beverage · Healthy volunteers aged 18–30 years | 10.5 g | 1 day | 19 |
| The effect of yellow pea protein and fibre on short-term food intake, subjective appetite and glycaemic response in healthy young men 2012 · F10 (10 g yellow pea fibre) · Healthy men aged 20–30 years | 10 g | 1 day | 19 |
| The effect of yellow pea protein and fibre on short-term food intake, subjective appetite and glycaemic response in healthy young men 2012 · F20 (20 g yellow pea fibre) · Healthy men aged 20–30 years | 20 g | 1 day | 19 |
| Chia induces clinically discrete weight loss and improves lipid profile only in altered previous values 2014 · CHIA · Men and women with overweight or obesity; ages 48.8 ± 1.8 years on average | 35 g | 12 weeks | 19 |
| Effects of Extrinsic Wheat Fiber Supplementation on Fecal Weight; A Randomized Controlled Trial 2020 · Extrinsic wheat fiber drink · Adults aged 18–30 years without stated intestinal disease or other specified health condition | 10 g | 5 days | 19 |
| Rhamnan sulphate from green algae Monostroma nitidum improves constipation with gut microbiome alteration in double-blind placebo-controlled trial 2021 · RS group · Healthy Japanese men and women aged 20–65 with low defaecation frequency (3–5 times per week) | 100 mg | 2 weeks | 19 |
| Oral Supplementation with Algal Sulphated Polysaccharide in Subjects with Inflammatory Skin Conditions: A Randomised Double-Blind Placebo-Controlled Trial and Baseline Dietary Differences 2023 · Group BA: SXRG84 for six weeks, then placebo for six weeks · Adults with inflammatory skin conditions, including psoriasis, eczema, rosacea or dermatitis; most were overweight, with healthy-weight participants also included | 2 g | 6 weeks | 19 |
| A specific dietary fibre supplementation improves cognitive performance-an exploratory randomised, placebo-controlled, crossover study 2021 · polydextrose (PDX) · Healthy female participants | 12.5 g | 4 weeks | 18 |
| Influence of a high-fibre food (myco-protein) on appetite: effects on satiation (within meals) and satiety (following meals) 1993 · Quorn myco-protein (high-fibre) meal · 18 lean, healthy male and female subjects | 11 g | 1 day | 18 |
| Cereal fiber improves whole-body insulin sensitivity in overweight and obese women 2006 · Fiber-enriched bread · Overweight or obese women with normal glucose metabolism | 31.2 g | 3 days | 17 |
| The effect of the gel-forming liquid fibre on feeding behaviour in man 1995 · liquid fibre · Healthy but overweight adult volunteers, 10 male and 7 female, with BMI 24–34 kg/m² | 900 mL | 1 day | 17 |
| Effects of Polydextrose Supplementation on Intestinal Function in Hemodialysis Patients: A Double-Blind, Randomized, Placebo-Controlled Trial 2023 · PDX group · Adults with end-stage kidney disease receiving hemodialysis; 7 females, median age 48.5 years (IQR 15.5) among completers | 12 g | 60 days | 16 |
| Insulin-sensitizing effects on muscle and adipose tissue after dietary fiber intake in men and women with metabolic syndrome 2012 · HAM-RS2 · Men and women with insulin resistance | 40 g | 8 weeks | 15 |
| Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial 2017 · 9 g SM group · Adults aged 18–65, male and female, with self-described unsatisfactory bowel habits | 9 g | 12 weeks | 15 |
| Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial 2017 · 12 g SM group · Adults aged 18–65, male and female, with self-described unsatisfactory bowel habits | 12 g | 12 weeks | 15 |
| Microbial enterotypes beyond genus level: Bacteroides species as a predictive biomarker for weight change upon controlled intervention with arabinoxylan oligosaccharides in overweight subjects 2020 · AXOS intervention · Men and women aged 18–60 years with overweight (BMI 25–40 kg/m²) and at least one metabolic-syndrome criterion | 10.4 g | 4 weeks | 15 |
| Randomised-controlled trial of a fibre supplement on the symptoms of irritable bowel syndrome 2005 · coarse wheat bran treatment group · Outpatients with constipation-predominant irritable bowel syndrome meeting the Rome criteria | 10 g | 12 weeks | 14 |
| Beneficial effects of resistant starch on laxation in healthy adults 2009 · resistant starch (RS) · Healthy adults; age and sex not reported | 25 g | 2 weeks | 14 |
| Beneficial effects of resistant starch on laxation in healthy adults 2009 · wheat bran (WB) · Healthy adults; age and sex not reported | 25 g | 2 weeks | 14 |
| Sugar and dietary fibre composition influence, by different hormonal response, the satiating capacity of a fruit-based and a β-glucan-enriched beverage 2012 · Fruit-based beverage · 14 healthy volunteers | 2.5 g | 1 day | 14 |
| Consumption of the Soluble Dietary Fibre Complex PolyGlycopleX(®) Reduces Glycaemia and Increases Satiety of a Standard Meal Postprandially 2016 · PGX granules · Healthy adults aged 19–32 years, 2 male and 12 female | 5 g | 1 day | 14 |
| Effect of tartaric acid and dietary fibre from sun-dried raisins on colonic function and on bile acid and volatile fatty acid excretion in healthy adults 2003 · sun-dried raisins · 13 healthy adults | 120 g | 3 weeks | 13 |
| Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms 2002 · Bran in patients with IBS · Patients with IBS meeting Rome I criteria and moderate to severe bloating | 30 g | 2 weeks | 12 |
| Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms 2002 · Bran in healthy controls · Healthy controls | 30 g | 2 weeks | 12 |
| Dietary fibre improves first-phase insulin secretion in overweight individuals 2012 · HAM-RS2 · Overweight adults, 8 men and 4 women, mean age 37 years, with insulin resistance and no diagnosed type 2 diabetes | 40 g | 4 weeks | 12 |
| Changes in meal composition and duration affect postprandial endothelial function in healthy humans 2014 · meal 2 · Healthy adults, mean age 33 ± 6 years; 6 male and 6 female | 9 g | 1 day | 12 |
| A New Dietary Fiber Can Enhance Satiety and Reduce Postprandial Blood Glucose in Healthy Adults: A Randomized Cross-Over Trial 2023 · RPG capsule experimental group (Cap) · Healthy adults aged 18–40 years; five women and seven men; no stated disease | 5.6 g | 1 day | 12 |
| Effect of bran particle size on gastric emptying and small bowel transit in humans: a scintigraphic study 1995 · Fine bran · Healthy volunteers; age and sex not reported | 15 g | 1 day | 12 |
| Effect of bran particle size on gastric emptying and small bowel transit in humans: a scintigraphic study 1995 · Coarse bran · Healthy volunteers; age and sex not reported | 15 g | 1 day | 12 |
| Gastrointestinal effects of modified guar gum and soy polysaccharide as part of an enteral formula diet 1992 · Modified guar gum diet · 11 healthy men | 15 g | 18 days | 11 |
| Gastrointestinal effects of modified guar gum and soy polysaccharide as part of an enteral formula diet 1992 · Soy polysaccharide diet · 11 healthy men | 15 g | 18 days | 11 |
| Adding more fluid to wheat bran has no significant effects on intestinal functions of healthy subjects 1991 · 15 g wheat bran twice a day without additional fluid · 11 healthy volunteers; age and sex not reported | 30 g | — | 11 |
| Adding more fluid to wheat bran has no significant effects on intestinal functions of healthy subjects 1991 · 15 g wheat bran twice a day with 600 mL additional fluid · 11 healthy volunteers; age and sex not reported | 30 g | — | 11 |
| Oligofructose promotes satiety in healthy human: a pilot study 2006 · oligofructose (OFS) · Healthy men and women aged 21–39 years, BMI 18.5–27.4 kg/m² | 16 g | 2 weeks | 10 |
| Effects of agar and pectin on gastric emptying and post-prandial glycaemic profiles in healthy human volunteers 2007 · agar meal · Healthy male volunteers | 2 g | 1 day | 10 |
| Effects of agar and pectin on gastric emptying and post-prandial glycaemic profiles in healthy human volunteers 2007 · pectin meal · Healthy male volunteers | 5.2 g | 1 day | 10 |
| Effects of Extrinsic Wheat Fiber Supplementation on Fecal Weight; A Randomized Controlled Trial 2020 · Extrinsic wheat fiber-enriched solid foods · Adults aged 18–30 years without stated intestinal disease or other specified health condition | 10 g | 5 days | 10 |
| Short-Term Effect of Additional Daily Dietary Fibre Intake on Appetite, Satiety, Gastrointestinal Comfort, Acceptability, and Feasibility 2022 · FibreMAX condition · Adults aged 18–50 years with BMI 18.5–34.9 kg/m², without the specified comorbidities | 50 g | 3 weeks | 10 |
| Effect of dietary oat and soy fiber on bowel function and clinical tolerance in a tube feeding dependent population 1994 · Ultracal · Medically stable, tube-feeding-dependent residents of a chronic care facility | 28.8 g | 10 days | 10 |
| Effects of Fructo-Oligosaccharide Supplementation on Constipation in Elderly Continuous Ambulatory Peritoneal Dialysis Patients 2016 · FOS · Elderly men and women with chronic constipation receiving continuous ambulatory peritoneal dialysis | 20 g | 30 days | 9 |
| Effect of training on the reliability of satiety evaluation and use of trained panellists to determine the satiety effect of dietary fibre: a randomised controlled trial 2015 · PGX fibre treatment breakfast · Healthy adults aged 19–53 years in a trained satiety expert panel | 5 g | 1 day | 9 |
| Effect of training on the reliability of satiety evaluation and use of trained panellists to determine the satiety effect of dietary fibre: a randomised controlled trial 2015 · Inulin control breakfast · Healthy adults aged 19–53 years in a trained satiety expert panel | 5 g | 1 day | 9 |
| Feasibility of Beans/Bran Enriching Nutritional Eating For Intestinal Health & Cancer Including Activity for Longevity: A Pilot Trial to Improve Healthy Lifestyles among Individuals at High Risk for Colorectal Cancer 2020 · Control group · Adults aged 18 or older with one or more adenomatous polyps removed within the previous 3 years | 10 g | 12 weeks | 9 |
| Effect of green lentils on colonic function, nitrogen balance, and serum lipids in healthy human subjects 1995 · diet supplemented with green lentils · Healthy males aged 19–38 years | 130 g | 3 weeks | 9 |
| A small dose of soluble alginate-fiber affects postprandial glycemia and gastric emptying in humans with diabetes 1991 · sodium alginate supplement · Seven men with well-controlled type 2 diabetes | 5 g | 1 day | 7 |
| Fermentability of an enzymatically modified solubilised potato polysaccharide (SPP) 1998 · 20 g SPP · Seven healthy volunteers; age and sex not specified | 20 g | 1 day | 7 |
| Fermentability of an enzymatically modified solubilised potato polysaccharide (SPP) 1998 · Bread baked of 180 g wheat flour and 20 g SPP · Seven healthy volunteers; age and sex not specified | 20 g | 1 day | 7 |
| Fermentability of an enzymatically modified solubilised potato polysaccharide (SPP) 1998 · 20 g lactulose · Seven healthy volunteers; age and sex not specified | 20 g | 1 day | 7 |
| Effects of wheat bran and Olestra on objective measures of stool and subjective reports of GI symptoms 2000 · wheat bran 20 g/day · Adults; sex and age range not reported; no stated condition | 20 g | 6 days | — |
| Effects of wheat bran and Olestra on objective measures of stool and subjective reports of GI symptoms 2000 · wheat bran 40 g/day · Adults; sex and age range not reported; no stated condition | 40 g | 6 days | — |
| Randomized clinical trial of soy formula with and without added fiber in antibiotic-induced diarrhea 2001 · Soy formula with added soy fiber · Older infants and toddlers who developed diarrhea while receiving antibiotics | 6.53 g | 10 days | — |
| High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG) 2002 · fiber (wheat bran diet) · Adults with irritable bowel syndrome (IBS), women and men; bowel-habit subtypes included diarrhea-predominant, constipation-predominant, and changeable | 30 g | 12 weeks | — |
| High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG) 2002 · PHGG · Adults with irritable bowel syndrome (IBS), women and men; bowel-habit subtypes included diarrhea-predominant, constipation-predominant, and changeable | 5 g | 12 weeks | — |
| Effects of cereal and vegetable fiber feeding on potential risk factors for colon cancer 1992 · 10 g fiber as wheat bran (WB) · Healthy volunteers; age and sex not reported | 10 g | 23 days | — |
| Effects of cereal and vegetable fiber feeding on potential risk factors for colon cancer 1992 · 30 g fiber as wheat bran (WB) · Healthy volunteers; age and sex not reported | 30 g | 23 days | — |
| Effects of cereal and vegetable fiber feeding on potential risk factors for colon cancer 1992 · 10 g fiber as vegetable fiber (VF) · Healthy volunteers; age and sex not reported | 10 g | 23 days | — |
| Effects of cereal and vegetable fiber feeding on potential risk factors for colon cancer 1992 · 30 g fiber as VF · Healthy volunteers; age and sex not reported | 30 g | 23 days | — |
| Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease 2007 · Rifaximin plus dietary fiber supplementation · Men and women aged 40–80 with symptomatic, uncomplicated colonic diverticular disease | 20 g | 2 years | — |
| Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease 2007 · Dietary fiber supplementation alone · Men and women aged 40–80 with symptomatic, uncomplicated colonic diverticular disease | 20 g | 2 years | — |
| Interaction between rifaximin and dietary fibre in patients with diverticular disease 2007 · Rifaximin-treated patients receiving bran · Patients with uncomplicated diverticular disease | 20 g | 2 weeks | — |
| Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial 2007 · guar gum · hypertensive, overweight patients; age and sex not specified | 10.5 g | 26 weeks | — |
| Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study 2007 · Guar gum supplementation · Adults aged 18–75 with resected colorectal cancer receiving adjuvant chemotherapy | 11 g | 24 weeks | — |
| Insoluble cereal fiber reduces appetite and short-term food intake and glycemic response to food consumed 75 min later by healthy men 2007 · high-fiber (HF) cereal · Young healthy men | 33 g | 1 day | — |
| Use of cereal fiber to facilitate adherence to a human caloric restriction program 2008 · +F (high-fiber cereal) · Healthy overweight men and women aged 20–42 years participating in a 30% caloric-restriction program | 20 g | 6 weeks | — |
| Effects of short-chain fructooligosaccharides on satiety responses in healthy men and women 2011 · 5 g scFOS · Healthy men and women; age range not reported | 10 g | 1 day | — |
| Effects of short-chain fructooligosaccharides on satiety responses in healthy men and women 2011 · 8 g scFOS · Healthy men and women; age range not reported | 16 g | 1 day | — |
| Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation 2011 · dried plums · Adults with chronic constipation; mean age 38 years; 3 male and 37 female | 100 g | 3 weeks | — |
| Dietary fibre added to very low calorie diet reduces hunger and alleviates constipation 1990 · VLCD with dietary fibre · Obese adults; sex and age range not reported | 30 g | 2 weeks | — |
| Overweight treated with energy restriction and a dietary fibre supplement: a 6-month randomized, double-blind, placebo-controlled trial 1990 · fibre-treated group · Overweight adults, 41 females and 11 males overall; mean BMI 29.3 | 7 g | 26 weeks | — |
| Digestive physiological outcomes related to polydextrose and soluble maize fibre consumption by healthy adult men 2011 · polydextrose (PDX) · healthy adult men | 21 g | 3 weeks | — |
| Digestive physiological outcomes related to polydextrose and soluble maize fibre consumption by healthy adult men 2011 · soluble maize fibre (SCF) · healthy adult men | 21 g | 3 weeks | — |
| Effect of alginate supplementation on weight loss in obese subjects completing a 12-wk energy-restricted diet: a randomized controlled trial 2012 · energy-restricted diet plus alginate-based preload supplement · Obese subjects | 15 g | 12 weeks | — |
| Improvement effect of resistant maltodextrin in humans with metabolic syndrome by continuous administration 2012 · RMD treatment group · Adults with metabolic syndrome; age range and sex not stated | 27 g | 12 weeks | — |
| Pectin is not pectin: a randomized trial on the effect of different physicochemical properties of dietary fiber on appetite and energy intake 2014 · bulking pectin · Young adult subjects, mean age 21±2 years; no condition reported | 10 g | 1 day | — |
| Pectin is not pectin: a randomized trial on the effect of different physicochemical properties of dietary fiber on appetite and energy intake 2014 · viscous pectin · Young adult subjects, mean age 21±2 years; no condition reported | 10 g | 1 day | — |
| Pectin is not pectin: a randomized trial on the effect of different physicochemical properties of dietary fiber on appetite and energy intake 2014 · gelled pectin in test product · Young adult subjects, mean age 21±2 years; no condition reported | 10 g | 1 day | — |
| Pectin is not pectin: a randomized trial on the effect of different physicochemical properties of dietary fiber on appetite and energy intake 2014 · gelled pectin capsules · Young adult subjects, mean age 21±2 years; no condition reported | 10 g | 1 day | — |
| Pectin is not pectin: a randomized trial on the effect of different physicochemical properties of dietary fiber on appetite and energy intake 2014 · gelled pectin liquid · Young adult subjects, mean age 21±2 years; no condition reported | 10 g | 1 day | — |
| Dose-response effect of a novel functional fibre, PolyGlycopleX(®), PGX(®), on satiety 2014 · PGX 2.5 g · Healthy subjects aged 20.3–29.2 years | 2.5 g | 1 day | — |
| Dose-response effect of a novel functional fibre, PolyGlycopleX(®), PGX(®), on satiety 2014 · PGX 5.0 g · Healthy subjects aged 20.3–29.2 years | 5 g | 1 day | — |
| Dose-response effect of a novel functional fibre, PolyGlycopleX(®), PGX(®), on satiety 2014 · PGX 7.5 g · Healthy subjects aged 20.3–29.2 years | 7.5 g | 1 day | — |
| The impact of oligofructose on stimulation of gut hormones, appetite regulation and adiposity 2014 · oligofructose · Healthy overweight and obese volunteers | 30 g | 6 weeks | — |
| Satiety effects of a whole-grain fibre composite ingredient: reduced food intake and appetite ratings 2014 · 20 g dose · adult men and women; age range and health status not reported | 20 g | 1 day | — |
| Satiety effects of a whole-grain fibre composite ingredient: reduced food intake and appetite ratings 2014 · 30 g dose · adult men and women; age range and health status not reported | 30 g | 1 day | — |
| [Clinical benefits after soluble dietary fiber supplementation: a randomized clinical trial in adults with slow-transit constipation] 2014 · fiber group · Adults with slow-transit constipation | 24 g | 4 weeks | — |
| α-Galacto-oligosaccharides Dose-Dependently Reduce Appetite and Decrease Inflammation in Overweight Adults 2015 · 6 g α-GOS/day dose group · Overweight adults aged 18–60 years, BMI 25–28 kg/m²; 50% men and 50% women | 6 g | 2 weeks | — |
| α-Galacto-oligosaccharides Dose-Dependently Reduce Appetite and Decrease Inflammation in Overweight Adults 2015 · 12 g α-GOS/day dose group · Overweight adults aged 18–60 years, BMI 25–28 kg/m²; 50% men and 50% women | 12 g | 2 weeks | — |
| α-Galacto-oligosaccharides Dose-Dependently Reduce Appetite and Decrease Inflammation in Overweight Adults 2015 · 18 g α-GOS/day dose group · Overweight adults aged 18–60 years, BMI 25–28 kg/m²; 50% men and 50% women | 18 g | 2 weeks | — |
| Effect of Polydextrose Intake on Constipation in Japanese Dialysis Patients: A Triple-Blind, Randomized, Controlled Trial 2015 · B (10 g polydextrose/d; PDX) · Japanese hemodialysis outpatients aged 51–79 who had used laxative tablets for more than 3 months and received hemodialysis for more than 6 months | 10 g | 8 weeks | — |
| Consuming yellow pea fiber reduces voluntary energy intake and body fat in overweight/obese adults in a 12-week randomized controlled trial 2017 · pea fiber (PF) · Overweight/obese adults, 9 men and 41 women, mean age 44 years | 15 g | 12 weeks | — |
| Effects of Resistant Glucan Mixture on Bowel Movement in Female Volunteers 2016 · 3.3 g/d RGM · Female volunteers with constipation; age range not reported | 3.3 g | 2 weeks | — |
| Effects of Resistant Glucan Mixture on Bowel Movement in Female Volunteers 2016 · 6.6 g/d RGM · Female volunteers with constipation; age range not reported | 6.6 g | 2 weeks | — |
| Effects of Resistant Glucan Mixture on Bowel Movement in Female Volunteers 2016 · 13.2 g/d RGM · Female volunteers with constipation; age range not reported | 13.2 g | 2 weeks | — |
| Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study 2017 · scFOS group · Patients with irritable bowel syndrome meeting Rome III criteria and rectal hypersensitivity | 5 g | 4 weeks | — |
| Effect of Fibre Supplementation on Body Weight and Composition, Frequency of Eating and Dietary Choice in Overweight Individuals 2017 · PGXG (Arm 2) · Adults aged 25–70 years with BMI 25–35 kg/m² who were overweight | 15 g | 12 weeks | — |
| Addition of Rye Bran and Pea Fiber to Pork Meatballs Enhances Subjective Satiety in Healthy Men, but Does Not Change Glycemic or Hormonal Responses: A Randomized Crossover Meal Test Study 2017 · pork meatballs plus fiber bread · Healthy men, mean age 23.3 years | 13 g | 1 day | — |
| Addition of Rye Bran and Pea Fiber to Pork Meatballs Enhances Subjective Satiety in Healthy Men, but Does Not Change Glycemic or Hormonal Responses: A Randomized Crossover Meal Test Study 2017 · fiber meatballs plus wheat bread · Healthy men, mean age 23.3 years | 13 g | 1 day | — |
| Addition of Rye Bran and Pea Fiber to Pork Meatballs Enhances Subjective Satiety in Healthy Men, but Does Not Change Glycemic or Hormonal Responses: A Randomized Crossover Meal Test Study 2017 · vegetable patties with natural fiber content plus wheat bread · Healthy men, mean age 23.3 years | 13 g | 1 day | — |
| The effect of soluble fiber dextrin on postprandial appetite and subsequent food intake in healthy adults 2018 · 10 g SFD beverage · Adults described as healthy; age range and sex not reported | 10 g | 1 day | — |
| The effect of soluble fiber dextrin on postprandial appetite and subsequent food intake in healthy adults 2018 · 20 g SFD beverage · Adults described as healthy; age range and sex not reported | 20 g | 1 day | — |
| Acute Effect of Resistant Starch on Food Intake, Appetite and Satiety in Overweight/Obese Males 2018 · resistant starch (RS) · Healthy overweight men aged 18–32 years | 48 g | 1 day | — |
| Anti-Heartburn Effects of Sugar Cane Flour: A Double-Blind, Randomized, Placebo-Controlled Study 2020 · PSCF intervention group · Men and women aged 18–75 with medically diagnosed GERD and heartburn and/or regurgitation at least three times a week | 3 g | 3 weeks | — |
| Intake of okara soup for 2 weeks for breakfast improved defecation habits in young Japanese women with self-reported constipation: A randomized, double-blind, placebo-controlled, intervention study 2020 · test group · Young Japanese women with self-reported constipation | 4.1 g | 2 weeks | — |
| Nopal fiber (Opuntia ficus-indica) improves symptoms in irritable bowel syndrome in the short term: a randomized controlled trial 2021 · 10 g/day nopal fiber · Patients with irritable bowel syndrome meeting Rome IV criteria; age and sex not reported | 10 g | 7 days | — |
| Nopal fiber (Opuntia ficus-indica) improves symptoms in irritable bowel syndrome in the short term: a randomized controlled trial 2021 · 20 g/day nopal fiber · Patients with irritable bowel syndrome meeting Rome IV criteria; age and sex not reported | 20 g | 7 days | — |
| Nopal fiber (Opuntia ficus-indica) improves symptoms in irritable bowel syndrome in the short term: a randomized controlled trial 2021 · 30 g/day nopal fiber · Patients with irritable bowel syndrome meeting Rome IV criteria; age and sex not reported | 30 g | 7 days | — |
| Visceral Fat-Reducing Effect and Safety of Continuous Consumption of Beverage Containing Resistant Maltodextrin: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial 2020 · Test group · Healthy adults | 15 g | 12 weeks | — |
| The Effects of High Fiber Rye, Compared to Refined Wheat, on Gut Microbiota Composition, Plasma Short Chain Fatty Acids, and Implications for Weight Loss and Metabolic Risk Factors (the RyeWeight Study) 2022 · rye group · Men and women aged 30–70 years with BMI 27–35 kg/m² | 30 g | 12 weeks | — |
| The Effects of High Fiber Rye, Compared to Refined Wheat, on Gut Microbiota Composition, Plasma Short Chain Fatty Acids, and Implications for Weight Loss and Metabolic Risk Factors (the RyeWeight Study) 2022 · wheat group · Men and women aged 30–70 years with BMI 27–35 kg/m² | 8 g | 12 weeks | — |
| Continuous partially hydrolyzed guar gum intake reduces cold-like symptoms: a randomized, placebo-controlled, double-blinded trial in healthy adults 2022 · PHGG group · Healthy Japanese adults; age and sex not specified | 5.2 g | 12 weeks | — |
| Effects of Dietary Supplementation with Carrot-Derived Rhamnogalacturonan-I (cRG-I) on Accelerated Protective Immune Responses and Quality of Life in Healthy Volunteers Challenged with Rhinovirus in a Randomized Trial 2022 · 0.3 g/d cRG-I group · Healthy adults aged 18–65 years | 300 mg | 10 weeks | — |
| Effects of Dietary Supplementation with Carrot-Derived Rhamnogalacturonan-I (cRG-I) on Accelerated Protective Immune Responses and Quality of Life in Healthy Volunteers Challenged with Rhinovirus in a Randomized Trial 2022 · 1.5 g/d cRG-I group · Healthy adults aged 18–65 years | 1.5 g | 10 weeks | — |
| Gastrointestinal Tolerability and Acute Glycemic Response of Oligosaccharides and Polysaccharides from Cellulose and Xylan in Healthy Adults: Two Double-Blinded, Randomized, Controlled, Cross-over Trials 2024 · 25 g/day PFE · Healthy adults | 25 g | 2 weeks | — |
| Gastrointestinal Tolerability and Acute Glycemic Response of Oligosaccharides and Polysaccharides from Cellulose and Xylan in Healthy Adults: Two Double-Blinded, Randomized, Controlled, Cross-over Trials 2024 · 35 g/day PFE · Healthy adults | 35 g | 2 weeks | — |
| Gastrointestinal Tolerability and Acute Glycemic Response of Oligosaccharides and Polysaccharides from Cellulose and Xylan in Healthy Adults: Two Double-Blinded, Randomized, Controlled, Cross-over Trials 2024 · 45 g/day PFE · Healthy adults | 45 g | 2 weeks | — |
| Effects of Soluble Dextrin Fiber from Potato Starch on Body Weight and Associated Gut Dysbiosis Are Evident in Western Diet-Fed Mice but Not in Overweight/Obese Children 2024 · prebiotic group · Children aged 5.7–10.2 years with overweight or obesity, both sexes | 10 g | 24 weeks | — |
| Pilot investigation of an oligosaccharide blend in adults with asthma - a double-blind, randomised, placebo-controlled, 4-arm crossover trial 2025 · HD2×6 · Adults with poorly controlled asthma | 12 g | 2 weeks | — |
| Pilot investigation of an oligosaccharide blend in adults with asthma - a double-blind, randomised, placebo-controlled, 4-arm crossover trial 2025 · HD12 · Adults with poorly controlled asthma | 12 g | 2 weeks | — |
| Pilot investigation of an oligosaccharide blend in adults with asthma - a double-blind, randomised, placebo-controlled, 4-arm crossover trial 2025 · LD · Adults with poorly controlled asthma | 6 g | 2 weeks | — |
| Effect of wheat bran in treatment of chronic nonorganic constipation. A double-blind controlled trial 1995 · bran · Patients with chronic nonorganic constipation | 20 g | 4 weeks | — |
| Gastrointestinal effects of sugarbeet fiber and wheat bran in healthy men 1993 · wheat bran (WB) · Healthy men | 20 g | — | — |
| Gastrointestinal effects of sugarbeet fiber and wheat bran in healthy men 1993 · sugarbeet fiber (SBF) · Healthy men | 20 g | — | — |
| Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial 2022 · Intervention Group (IG) · Hospitalized men and women aged 30–75 years with stage III COVID-19, oxygen saturation below 90%, and comorbidities including type 2 diabetes, systemic arterial hypertension, or BMI 25–40 | 40 g | 3 weeks | 40 |
| Consuming a Protein and Fiber-Based Supplement Preload Promotes Weight Loss and Alters Metabolic Markers in Overweight Adults in a 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial 2022 · HPF (high-protein, high-fiber supplement shake) · Adults aged 25–50 with overweight or obesity (BMI 27.0–35.0) | 12 g | 12 weeks | 103 |
| Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial 2023 · Group A · Adults aged 18–70 with functional constipation | 1.5 g | 4 weeks | 50 |
| Efficacy of Polydextrose Supplementation on Colonic Transit Time, Bowel Movements, and Gastrointestinal Symptoms in Adults: A Double-Blind, Randomized, Placebo-Controlled Trial 2019 · 12 g PDX group · Adults aged 18–70 with functional constipation meeting Rome III criteria | 12 g | 2 weeks | 48 |
| Efficacy of Polydextrose Supplementation on Colonic Transit Time, Bowel Movements, and Gastrointestinal Symptoms in Adults: A Double-Blind, Randomized, Placebo-Controlled Trial 2019 · 8 g PDX group · Adults aged 18–70 with functional constipation meeting Rome III criteria | 8 g | 2 weeks | 48 |
| Efficacy of Polydextrose Supplementation on Colonic Transit Time, Bowel Movements, and Gastrointestinal Symptoms in Adults: A Double-Blind, Randomized, Placebo-Controlled Trial 2019 · 4 g PDX group · Adults aged 18–70 with functional constipation meeting Rome III criteria | 4 g | 2 weeks | 48 |
| The effects of probiotics plus dietary fiber on antipsychotic-induced weight gain: a randomized clinical trial 2022 · Probiotics plus dietary fiber · Adults aged 18–45 with schizophrenia or bipolar disorder, receiving atypical antipsychotics and with more than 10% weight gain | 60 g | 12 weeks | 34 |
| Improvements in quality-of-life dimensions through medium-chain triglyceride (MCT) supplementation in rheumatoid arthritis: updated findings from a randomised clinical trial 2026 · test group, second 8 weeks · Adults with rheumatoid arthritis and low to moderate disease activity; age range and sex distribution not stated | 30 g | 8 weeks | 32 |
| Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naïve First-Episode Schizophrenia Patients: Two Randomized Clinical Trials 2022 · Olanzapine and probiotics plus dietary fiber (Study 2) · Adults aged 18–50 with drug-naïve first-episode schizophrenia | 60 g | 12 weeks | 30 |
| Novel calcium-gelled, alginate-pectin beverage reduced energy intake in nondieting overweight and obese women: interactions with dietary restraint status 2007 · 1.0-g alginate-pectin formulation · Overweight and obese women; age range and condition details beyond overweight/obesity not stated | 2 g | 7 days | 29 |
| Novel calcium-gelled, alginate-pectin beverage reduced energy intake in nondieting overweight and obese women: interactions with dietary restraint status 2007 · 2.8-g alginate-pectin formulation · Overweight and obese women; age range and condition details beyond overweight/obesity not stated | 5.6 g | 7 days | 29 |
| Probiotics, soluble fiber, and L-Glutamine (GLN) reduce nelfinavir (NFV)- or lopinavir/ritonavir (LPV/r)-related diarrhea 2004 · Supplement group · HIV-positive men with diarrhea receiving nelfinavir- or lopinavir/ritonavir-containing antiretroviral therapy | 11 g | 12 weeks | 28 |
| A randomized dietary intervention to increase colonic and peripheral blood SCFAs modulates the blood B- and T-cell compartments in healthy humans 2022 · High-SCFA (H-SCFA) diet · Healthy adults aged 18–45 years, men and women | 20 g | 3 weeks | 22 |
| Effect of cooked white rice with high β-glucan barley on appetite and energy intake in healthy Japanese subjects: a randomized controlled trial 2014 · BAR (cooked white rice with β-glucan enriched barley) · Healthy Japanese women aged 30–49 years, BMI >22 and <25 kg/m² | 5.3 g | 1 day | 21 |
| Viscosity of oat bran-enriched beverages influences gastrointestinal hormonal responses in healthy humans 2009 · low-viscosity oat bran beverage · Healthy, normal-weight adults aged 22.6 years on average; 16 female and 4 male | 10.2 g | 1 day | 20 |
| Viscosity of oat bran-enriched beverages influences gastrointestinal hormonal responses in healthy humans 2009 · high-viscosity oat bran beverage · Healthy, normal-weight adults aged 22.6 years on average; 16 female and 4 male | 10.2 g | 1 day | 20 |
| L-arginine enriched biscuits improve endothelial function and glucose metabolism: a pilot study in healthy subjects and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome 2013 · L-arginine-enriched biscuits (crossover study) · 15 obese subjects with impaired glucose tolerance and metabolic syndrome | 4.3 g | 2 weeks | 15 |
| Consumption of the Soluble Dietary Fibre Complex PolyGlycopleX(®) Reduces Glycaemia and Increases Satiety of a Standard Meal Postprandially 2016 · PGX softgel · Healthy adults aged 19–32 years, 2 male and 12 female | 4.5 g | 1 day | 14 |
| Consumption of yacon flour improves body composition and intestinal function in overweight adults: A randomized, double-blind, placebo-controlled clinical trial 2019 · yacon flour · Adults with excess weight (mean age 31.3 years; sex not specified) | 100 mg/kg | 6 weeks | 13 |
| Post-prandial responses to cereal products enriched with barley beta-glucan 2006 · Barley crackers (BCr) · Healthy volunteers; 10 adults, 5 male, mean age 25.4 years | 12 g | 1 day | 10 |
| Post-prandial responses to cereal products enriched with barley beta-glucan 2006 · Barley cookies (Bc) · Healthy volunteers; 10 adults, 5 male, mean age 25.4 years | 12 g | 1 day | 10 |
| Yoghurt containing galacto-oligosaccharides, prunes and linseed reduces the severity of mild constipation in elderly subjects 2007 · test yoghurt · Elderly adults aged 61–92 with self-reported constipation | 30 g | 3 weeks | — |
| Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study 2007 · Lactobacillus plus guar gum supplementation · Adults aged 18–75 with resected colorectal cancer receiving adjuvant chemotherapy | 11 g | 24 weeks | — |
| Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial 2008 · b.i.d. group · Overweight or obese patients; age and sex not specified | 6 g | 16 weeks | — |
| Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial 2008 · t.i.d. group · Overweight or obese patients; age and sex not specified | 9 g | 16 weeks | — |
| [The effect of a fibre enriched dietary milk product in chronic primary idiopatic constipation] 2008 · Group A (fibre-enriched semi-skimmed milk) · Adults, men and women, mean age 47 ± 15 years, with chronic primary constipation meeting Rome II criteria | 20 g | 20 days | — |
| Microbiota benefits after inulin and partially hydrolized guar gum supplementation: a randomized clinical trial in constipated women 2012 · fiber group · Constipated female health-worker volunteers reporting fewer than 3 bowel movements per week | 15 g | 3 weeks | — |
| Efficacy of synbiotics to reduce acute radiation proctitis symptoms and improve quality of life: a randomized, double-blind, placebo-controlled pilot trial 2014 · synbiotic · Patients with prostate cancer receiving 3-dimensional conformal radiation therapy; age and sex not specified | 4.3 g | 4 weeks | — |
| Efficacy of Synbiotics to Reduce Symptoms and Rectal Inflammatory Response in Acute Radiation Proctitis: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial 2020 · synbiotic · Patients with prostate cancer receiving radiotherapy | 4.3 g | 7 weeks | — |
| The effect of inulin and resistant maltodextrin on weight loss during energy restriction: a randomised, placebo-controlled, double-blinded intervention 2020 · inulin plus resistant maltodextrin · Overweight or obese participants; age and sex not specified | 10 g | 12 weeks | — |
| Effects of whey protein and dietary fiber intake on insulin sensitivity, body composition, energy expenditure, blood pressure, and appetite in subjects with abdominal obesity 2021 · whey protein hydrolysate with high-fiber cereal products · Adults with abdominal obesity | 30 g | 12 weeks | — |
| Effects of whey protein and dietary fiber intake on insulin sensitivity, body composition, energy expenditure, blood pressure, and appetite in subjects with abdominal obesity 2021 · whey protein hydrolysate with low-fiber cereal products · Adults with abdominal obesity | 10 g | 12 weeks | — |
| Dietary Blueberry and Soluble Fiber Supplementation Reduces Risk of Gestational Diabetes in Women with Obesity in a Randomized Controlled Trial 2021 · intervention · Women with obesity recruited before 20 weeks of pregnancy; mean age 27 ± 5 years | 12 g | 18 weeks | — |
| Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination 1993 · senna-fibre combination · Elderly patients with chronic constipation in long-term hospital or nursing-home care | 10 mL | 2 weeks | — |
| Gut microbiome predicts personalized responses to dietary fiber in prediabetes: a randomized, open-label trial 2025 · W group (dietary fiber intervention group) · Adults aged 30–75 with prediabetes | 45 g | 26 weeks | 409 |
| Soluble fibre (Plantago ovata husk) reduces plasma low-density lipoprotein (LDL) cholesterol, triglycerides, insulin, oxidised LDL and systolic blood pressure in hypercholesterolaemic patients: A randomised trial 2010 · Plantago ovata husk group · Adults aged 43–67 years with mild-to-moderate hypercholesterolaemia | 14 g | 8 weeks | 126 |
| Long-term blood cholesterol-lowering effects of a dietary fiber supplement 1999 · fiber supplement · People with mild to moderate hypercholesterolemia | 20 g | 51 weeks | 87 |
| Long-term treatment of hypercholesterolemia with dietary fiber 1994 · dietary fiber treatment · Subjects with moderate hypercholesterolemia following a National Cholesterol Education Program Step-One Diet | 20 g | 36 weeks | 59 |
| Impact of a high dietary fiber cereal meal intervention on the progression of liver fibrosis in T2DM with MASLD 2025 · Intervention with 12 g · Adults aged 40–70 with type 2 diabetes mellitus and MASLD | 12 g | 12 weeks | 39 |
| Impact of a high dietary fiber cereal meal intervention on the progression of liver fibrosis in T2DM with MASLD 2025 · Intervention with 24 g · Adults aged 40–70 with type 2 diabetes mellitus and MASLD | 24 g | 12 weeks | 39 |
| Evaluating the Effects of Corn Flour Product Consumption on Cardiometabolic Outcomes and the Gut Microbiota in Adults with Elevated Cholesterol: A Randomized Crossover 2024 · WCM (whole-grain corn meal) · Adults aged 18–67 with mildly to moderately elevated LDL cholesterol | 48 g | 4 weeks | 36 |
| Evaluating the Effects of Corn Flour Product Consumption on Cardiometabolic Outcomes and the Gut Microbiota in Adults with Elevated Cholesterol: A Randomized Crossover 2024 · RCM + B (refined corn meal and corn bran blend) · Adults aged 18–67 with mildly to moderately elevated LDL cholesterol | 48 g | 4 weeks | 36 |
| Evaluating the Effects of Corn Flour Product Consumption on Cardiometabolic Outcomes and the Gut Microbiota in Adults with Elevated Cholesterol: A Randomized Crossover 2024 · RCM (refined corn meal) · Adults aged 18–67 with mildly to moderately elevated LDL cholesterol | 48 g | 4 weeks | 36 |
| A dietary fibre supplement in the treatment of mild hypertension. A randomized, double-blind, placebo-controlled trial 1992 · fibre · mildly hypertensive patients with at least two diastolic blood pressure readings above 90 mmHg during a 2-week run-in period | 7 g | 90 days | 32 |
| Carob pulp preparation rich in insoluble fibre lowers total and LDL cholesterol in hypercholesterolemic patients 2003 · carob fibre group · Adults with hypercholesterolemia | 15 g | 6 weeks | 29 |
| Effects of legume kernel fibres and citrus fibre on putative risk factors for colorectal cancer: a randomised, double-blind, crossover human intervention trial 2013 · Citrus fibre in blue-lupin group · Healthy men and women aged 20–45 years | 25 g | 2 weeks | 26 |
| Effects of legume kernel fibres and citrus fibre on putative risk factors for colorectal cancer: a randomised, double-blind, crossover human intervention trial 2013 · Citrus fibre in white-lupin group · Healthy men and women aged 20–45 years | 25 g | 2 weeks | 26 |
| Effects of legume kernel fibres and citrus fibre on putative risk factors for colorectal cancer: a randomised, double-blind, crossover human intervention trial 2013 · Soya kernel fibre · Healthy men and women aged 20–45 years | 25 g | 2 weeks | 26 |
| Effects of legume kernel fibres and citrus fibre on putative risk factors for colorectal cancer: a randomised, double-blind, crossover human intervention trial 2013 · Citrus fibre in soya group · Healthy men and women aged 20–45 years | 25 g | 2 weeks | 26 |
| The effect of dietary fiber (oat bran) supplement on blood pressure in patients with essential hypertension: A randomized controlled trial 2021 · DF group · Patients with essential hypertension; age and sex not reported | 30 g | 90 days | 25 |
| Viscosity rather than quantity of dietary fibre predicts cholesterol-lowering effect in healthy individuals 2011 · low-viscosity wheat bran (WB) · Apparently healthy adults aged 35 years on average, consuming a typical North American diet; 12 males and 11 females | 10.8 g | 3 weeks | 23 |
| Viscosity rather than quantity of dietary fibre predicts cholesterol-lowering effect in healthy individuals 2011 · high-viscosity viscous fibre blend (VFB) · Apparently healthy adults aged 35 years on average, consuming a typical North American diet; 12 males and 11 females | 5.1 g | 3 weeks | 23 |
| Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL, and HDL subfraction distribution and size in overweight men 2006 · soluble fiber supplement · Overweight men participating in a weight-loss intervention; age range not reported | 3 g | 12 weeks | 14 |
| [Effects of dietary fiber and insulin treatment on serum levels of lipids and lipoprotein (a) in patients with type II diabetes mellitus] 1992 · guar gum bread · Adults with type II diabetes mellitus, mean age 62 years, treated with oral antidiabetic agents | 11.2 g | 90 days | 12 |
| Highlights of three metabolites HDL and reduction in blood pressure values after dietary fiber supplementation in overweight and obese normotensive women: a metabolomic study 2023 · G1 (mixed dietary fiber group) · Women aged 20–50 years with overweight or obesity who were normotensive | 12 g | 8 weeks | 11 |
| Cholesterol lowering with high-viscosity hydroxypropylmethylcellulose 1999 · 2.5 g/day HPMC · Patients with mild to moderate hypercholesterolemia and LDL cholesterol of 130–200 mg/dl | 2.5 g | 6 weeks | — |
| Cholesterol lowering with high-viscosity hydroxypropylmethylcellulose 1999 · 5.0 g/day HPMC · Patients with mild to moderate hypercholesterolemia and LDL cholesterol of 130–200 mg/dl | 5 g | 6 weeks | — |
| Cholesterol lowering with high-viscosity hydroxypropylmethylcellulose 1999 · 7.5 g/day HPMC · Patients with mild to moderate hypercholesterolemia and LDL cholesterol of 130–200 mg/dl | 7.5 g | 6 weeks | — |
| High-molecular-weight hydroxypropylmethylcellulose taken with or between meals is hypocholesterolemic in adult men 2000 · Between Meals group · Adult men with mild-to-moderate hypercholesterolemia | 5 g | 2 weeks | — |
| High-molecular-weight hydroxypropylmethylcellulose taken with or between meals is hypocholesterolemic in adult men 2000 · With Meals group · Adult men with mild-to-moderate hypercholesterolemia | 5 g | 2 weeks | — |
| Is dietary fiber beneficial in chronic ischemic heart disease? 2000 · fiber (F) group · Adults with chronic ischemic heart disease | 20 g | 26 weeks | — |
| Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: a pilot trial 2002 · oat cereal group · men and women with mild or borderline hypertension and hyperinsulinemia (insulin ≥10 U/mL); age range not reported | 5.52 g | 6 weeks | — |
| High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-aged and older men 2002 · oat cereal · Overweight men aged 50–75 years | 14 g | 12 weeks | — |
| High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-aged and older men 2002 · wheat cereal · Overweight men aged 50–75 years | 14 g | 12 weeks | — |
| Role of water-soluble dietary fiber in the management of elevated plasma cholesterol in healthy subjects 1992 · WSDF, 5 g/day · Healthy men and women with plasma cholesterol greater than 5.17 mmol/L (greater than 200 mg/dL) | 5 g | — | — |
| Role of water-soluble dietary fiber in the management of elevated plasma cholesterol in healthy subjects 1992 · WSDF, 10 g/day · Healthy men and women with plasma cholesterol greater than 5.17 mmol/L (greater than 200 mg/dL) | 10 g | — | — |
| Role of water-soluble dietary fiber in the management of elevated plasma cholesterol in healthy subjects 1992 · WSDF, 15 g/day · Healthy men and women with plasma cholesterol greater than 5.17 mmol/L (greater than 200 mg/dL) | 15 g | — | — |
| A factorial study of salt restriction and a low-fat/high-fibre diet in hypertensive subjects 1992 · Low-sodium, low-fat/high-fibre diet; placebo for sodium · Hypertensive adults, mean age 53.5 years | 30 g | 8 weeks | — |
| Lathosterol and other noncholesterol sterols during treatment of hypercholesterolemia with lovastatin alone and with cholestyramine or guar gum 1992 · L + GG · Patients aged 19–64 years with primary hypercholesterolemia | 20 g | 36 weeks | — |
| Effect of oatbran on mild hyperlipidaemia 1992 · oatbran muffins · Adults with mild hyperlipidaemia and serum cholesterol of 5.5–8.0 mmol/L; 16 men and 21 women were recruited | 60 g | 8 weeks | — |
| Effect of soluble fiber intake in lipid and glucose levels in healthy subjects: a randomized clinical trial 2004 · Group I · Healthy subjects; age and sex not reported | 10.4 g | 90 days | — |
| Effect of soluble fiber intake in lipid and glucose levels in healthy subjects: a randomized clinical trial 2004 · Group II · Healthy subjects; age and sex not reported | 30.5 g | 90 days | — |
| Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods 2010 · Whole-grain RTE oat cereal group · Adults with overweight or obesity (BMI 25–45) and baseline LDL cholesterol of 130–200 mg/dL | 3 g | 12 weeks | — |
| Cholesterol-lowering properties of different pectin types in mildly hyper-cholesterolemic men and women 2012 · citrus pectin DE-70 (4-week trial) · Mildly hyper-cholesterolemic men and women | 15 g | 4 weeks | — |
| Cholesterol-lowering properties of different pectin types in mildly hyper-cholesterolemic men and women 2012 · citrus pectin DE-35 (4-week trial) · Mildly hyper-cholesterolemic men and women | 15 g | 4 weeks | — |
| Cholesterol-lowering properties of different pectin types in mildly hyper-cholesterolemic men and women 2012 · orange pulp fiber DE-70 (4-week trial) · Mildly hyper-cholesterolemic men and women | 15 g | 4 weeks | — |
| Cholesterol-lowering properties of different pectin types in mildly hyper-cholesterolemic men and women 2012 · low-MW pectin DE-70 (4-week trial) · Mildly hyper-cholesterolemic men and women | 15 g | 4 weeks | — |
| Cholesterol-lowering properties of different pectin types in mildly hyper-cholesterolemic men and women 2012 · citrus pectin DE-0 (4-week trial) · Mildly hyper-cholesterolemic men and women | 15 g | 4 weeks | — |
| Cholesterol-lowering properties of different pectin types in mildly hyper-cholesterolemic men and women 2012 · citrus pectin DE-70 (3-week trial) · Mildly hyper-cholesterolemic men and women | 6 g | 3 weeks | — |
| Cholesterol-lowering properties of different pectin types in mildly hyper-cholesterolemic men and women 2012 · high-MW pectin DE-70 (3-week trial) · Mildly hyper-cholesterolemic men and women | 6 g | 3 weeks | — |
| Effect of soluble corn fibre and calcium supplementation on bone mineral content and bone mineral density in preadolescent Malaysian children-a double-blind randomised controlled trial (PREBONE-Kids Study) 2023 · 12-g SCF · Healthy Malaysian children aged 9–11 years | 12 g | 1 year | — |
| Cookies enriched with psyllium or oat bran lower plasma LDL cholesterol in normal and hypercholesterolemic men from Northern Mexico 1998 · Oat bran group · Sedentary men aged 20–45 years from Northern Mexico, normal or hypercholesterolemic | 2.6 g | 8 weeks | — |
| Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial 2023 · Group C · Adults aged 18–70 with functional constipation | 6 g | 4 weeks | 50 |
| Effects of a mixed berry beverage on cognitive functions and cardiometabolic risk markers; A randomized cross-over study in healthy older adults 2017 · Berry beverage · Healthy men and women aged 50–70 years with BMI ≤28 kg/m² | 11 g | 5 weeks | 40 |
| A prospective randomized comparative trial evaluating postoperative nutritional intervention in patients with oral cancer 2022 · Intervention group · Adults with oral cancer after surgery; ages 18 and older, both sexes | 5 g | 26 weeks | 22 |
| Consumption of a dietary portfolio of cholesterol lowering foods improves blood lipids without affecting concentrations of fat soluble compounds 2014 · Portfolio routine · Adult men and postmenopausal women with hyperlipidemia and low-to-intermediate Framingham 10-year risk | 9.8 g | 26 weeks | 122 |
| Consumption of a dietary portfolio of cholesterol lowering foods improves blood lipids without affecting concentrations of fat soluble compounds 2014 · Portfolio intensive · Adult men and postmenopausal women with hyperlipidemia and low-to-intermediate Framingham 10-year risk | 9.8 g | 26 weeks | 101 |
| Cocoa, hazelnuts, sterols and soluble fiber cream reduces lipids and inflammation biomarkers in hypertensive patients: a randomized controlled trial 2012 · Product LMN (cocoa+hazelnuts+phytosterols+soluble fiber cream) · Men and women older than 20 with prehypertension or stage-1 hypertension, LDL cholesterol 3.35–4.88 mmol/L, and at least one cardiovascular risk factor | 20 g | 4 weeks | 27 |
| Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects 2001 · Abalon · Adults with type 2 diabetes | 20 g | 6 weeks | — |
| A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects 2002 · 30 g isolated soy protein and 10 g cotyledon fiber · Men and women with LDL-cholesterol concentrations ≥4 mmol/L | 10 g | 16 weeks | — |
| A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects 2002 · 50 g isolated soy protein and 16.6 g cotyledon fiber · Men and women with LDL-cholesterol concentrations ≥4 mmol/L | 16.6 g | 16 weeks | — |
| Effects of soy supplementation on blood lipids and arterial function in hypercholesterolaemic subjects 2005 · soy supplement (Abalon) · Hypercholesterolaemic but otherwise healthy adults; age range and sex not stated | 9 g | 24 weeks | — |
| The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. A dose-controlled study 1991 · 28 g oatmeal · Adults with LDL-C above 4.14 mmol/L or LDL-C between 3.37 and 4.14 mmol/L with multiple risk factors | 28 g | 6 weeks | — |
| The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. A dose-controlled study 1991 · 56 g oatmeal · Adults with LDL-C above 4.14 mmol/L or LDL-C between 3.37 and 4.14 mmol/L with multiple risk factors | 56 g | 6 weeks | — |
| The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. A dose-controlled study 1991 · 84 g oatmeal · Adults with LDL-C above 4.14 mmol/L or LDL-C between 3.37 and 4.14 mmol/L with multiple risk factors | 84 g | 6 weeks | — |
| The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. A dose-controlled study 1991 · 28 g oat bran · Adults with LDL-C above 4.14 mmol/L or LDL-C between 3.37 and 4.14 mmol/L with multiple risk factors | 28 g | 6 weeks | — |
| The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. A dose-controlled study 1991 · 56 g oat bran · Adults with LDL-C above 4.14 mmol/L or LDL-C between 3.37 and 4.14 mmol/L with multiple risk factors | 56 g | 6 weeks | — |
| The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. A dose-controlled study 1991 · 84 g oat bran · Adults with LDL-C above 4.14 mmol/L or LDL-C between 3.37 and 4.14 mmol/L with multiple risk factors | 84 g | 6 weeks | — |
| Co-administration of a konjac-based fibre blend and American ginseng (Panax quinquefolius L.) on glycaemic control and serum lipids in type 2 diabetes: a randomized controlled, cross-over clinical trial 2018 · KGB and AG · Adults with type 2 diabetes, aged 64 ± 7 years; 18 men and 12 women completed the study | 6 g | 12 weeks | — |
| Effect of soluble corn fibre and calcium supplementation on bone mineral content and bone mineral density in preadolescent Malaysian children-a double-blind randomised controlled trial (PREBONE-Kids Study) 2023 · 12-g SCF + 600-mg calcium lactate gluconate (SCF + Ca) · Healthy Malaysian children aged 9–11 years | 12 g | 1 year | — |
| Co-administration of viscous fiber, Salba-chia and ginseng on glycemic management in type 2 diabetes: a double-blind randomized controlled trial 2021 · active intervention · Adults with type 2 diabetes, mean age 59 years; 60 men and 44 women across the trial | 10 g | 24 weeks | 52 |
| Co-administration of viscous fiber, Salba-chia and ginseng on glycemic management in type 2 diabetes: a double-blind randomized controlled trial 2021 · control intervention · Adults with type 2 diabetes, mean age 59 years; 60 men and 44 women across the trial | 55.3 g | 24 weeks | 52 |
| Reduction in Serum LDL Cholesterol Using a Nutrient Compendium in Hyperlipidemic Adults Unable or Unwilling to Use Statin Therapy: A Double-Blind Randomized Crossover Clinical Trial 2022 · Treatment foods · Adult men and women with hyperlipidemia who were unable or unwilling to use statin therapy | 10 g | 4 weeks | — |
| Chronic dietary fiber supplementation with wheat dextrin does not inhibit calcium and magnesium absorption in premenopausal and postmenopausal women 2011 · wheat dextrin · Premenopausal and postmenopausal women, mean age 49.9 years | 15 g | 2 weeks | 40 |
| Oats Lower Age-Related Systemic Chronic Inflammation (iAge) in Adults at Risk for Cardiovascular Disease 2022 · OBG (oat product) group · Healthy men and women aged 21–65 with moderate-to-elevated LDL-cholesterol levels | 3 g | 4 weeks | 96 |
| Fibre supplementation for the prevention of type 2 diabetes and improvement of glucose metabolism: the randomised controlled Optimal Fibre Trial (OptiFiT) 2018 · fibre supplement group · Adult men and women with impaired glucose tolerance | 15 g | 2 years | 89 |
| Randomized controlled trial of oatmeal consumption versus noodle consumption on blood lipids of urban Chinese adults with hypercholesterolemia 2012 · Oat group · Men and women aged 35–70 with mild to moderate hypercholesterolemia | 3.6 g | 6 weeks | 85 |
| The prebiotic effects of soluble dietary fiber mixture on renal anemia and the gut microbiota in end-stage renal disease patients on maintenance hemodialysis: a prospective, randomized, placebo-controlled study 2022 · DF intervention group · Adults aged 18–80 with end-stage renal disease on maintenance hemodialysis and renal anemia (hemoglobin <110 g/L) | 10 g | 8 weeks | 81 |
| Randomized double blind clinical trial on the effect of oral α-cyclodextrin on serum lipids 2016 · α-CD · Healthy adults aged 18–75, male and female, without diabetes or obesity | 6 g | 14 weeks | 75 |
| Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial 2002 · high-fiber diet · Hyperlipidemic adults; age and sex not specified | 8 g | 30 days | 68 |
| Improved Plasma Lipids, Anti-Inflammatory Activity, and Microbiome Shifts in Overweight Participants: Two Clinical Studies on Oral Supplementation with Algal Sulfated Polysaccharide 2022 · SXRG84 treatment phase (Study 2) · Adults with overweight BMI (25 to under 30 kg/m²), aged 18 years or older; average age 52 years | 2 g | 6 weeks | 64 |
| NUTRIOSE dietary fiber supplementation improves insulin resistance and determinants of metabolic syndrome in overweight men: a double-blind, randomized, placebo-controlled study 2010 · Test group · Overweight Chinese men, mean age 30.4 years | 34 g | 12 weeks | 60 |
| NUTRIOSE dietary fiber supplementation improves insulin resistance and determinants of metabolic syndrome in overweight men: a double-blind, randomized, placebo-controlled study 2010 · Test group · Overweight Chinese men, mean age 30.4 years | 34 g | 12 weeks | 60 |
| Interventional effect of dietary fiber on blood glucose and pregnancy outcomes in patients with gestational diabetes mellitus 2021 · dietary fiber group · Pregnant patients in the second trimester with gestational diabetes mellitus | 9.5 g | 8 weeks | 56 |
| Effect on Insulin, Glucose and Lipids in Overweight/Obese Australian Adults of 12 Months Consumption of Two Different Fibre Supplements in a Randomised Trial 2017 · PGX supplement group (PGX) · Adults aged 19–68 years with overweight or obesity (BMI 25–47 kg/m²) | 15 g | 52 weeks | 53 |
| The effect of oat bran consumption on gestational diabetes: a randomized controlled clinical trial 2021 · Cases: standard diet with oat bran · Pregnant women aged 18–35 years, screened at 24–28 weeks of gestation with impaired blood sugar and gestational diabetes | 60 g | 4 weeks | 51 |
| The impact of daily supplementation with rhamnogalacturonan-I on the gut microbiota in healthy adults: A randomized controlled trial 2024 · high-dose group · Healthy adults challenged with rhinovirus RV16 | 1.5 g | 8 weeks | 51 |
| Fecal bile acid concentrations in a subpopulation of the wheat bran fiber colon polyp trial 2003 · high fiber (13.5 g/day) intervention group · People enrolled in a Phase III trial for prevention of adenomatous polyp recurrence | 13.5 g | 876 days | 49 |
| Additional Resistant Starch from One Potato Side Dish per Day Alters the Gut Microbiota but Not Fecal Short-Chain Fatty Acid Concentrations 2022 · POT (potato-based side dish) · Healthy adults aged 25–75 years, both sexes, without chronic disease | 3.6 g | 4 weeks | 49 |
| The impact of daily supplementation with rhamnogalacturonan-I on the gut microbiota in healthy adults: A randomized controlled trial 2024 · low-dose group · Healthy adults challenged with rhinovirus RV16 | 300 mg | 8 weeks | 49 |
| The effects of the combination of egg and fiber on appetite, glycemic response and food intake in normal weight adults - a randomized, controlled, crossover trial 2016 · moderate-protein egg-based breakfast · Healthy adults; mean age 24 years; normal weight (mean BMI 23 kg/m²) | 7 g | 1 day | 48 |
| Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch 2011 · 25 g NSP diet · Healthy adults aged 31–66 years, male and female | 25 g | 4 weeks | 46 |
| Insoluble carob fiber rich in polyphenols lowers total and LDL cholesterol in hypercholesterolemic sujects 2010 · fiber · Adults with hypercholesterolemia | 8 g | 4 weeks | 43 |
| The effects of functional fiber on postprandial glycemia, energy intake, satiety, palatability and gastrointestinal wellbeing: a randomized crossover trial 2014 · FibreMax™ bread · University students aged 18–35 years, with normal BMI and fasting blood glucose | 15 g | 1 day | 43 |
| Wheat-bran and oat-bran supplements' effects on blood lipids and lipoproteins 1992 · wheat bran · Healthy middle-aged men and women | 16.4 g | 2 weeks | 42 |
| Wheat-bran and oat-bran supplements' effects on blood lipids and lipoproteins 1992 · oat bran · Healthy middle-aged men and women | 16.4 g | 2 weeks | 42 |
| Obesity Does Not Modulate the Glycometabolic Benefit of Insoluble Cereal Fibre in Subjects with Prediabetes-A Stratified Post Hoc Analysis of the Optimal Fibre Trial (OptiFiT) 2019 · OBESE fibre group · Adults with impaired glucose tolerance and obesity (BMI ≥30 kg/m²); age and sex range not specified | 15 g | 1 year | 41 |
| Do beans and oat bran add to the effectiveness of a low-fat diet? 1992 · low-fibre oat bran · hypercholesterolaemic men and women | 55 g | 6 weeks | 40 |
| Do beans and oat bran add to the effectiveness of a low-fat diet? 1992 · high-fibre oat bran · hypercholesterolaemic men and women | 55 g | 6 weeks | 40 |
| Do beans and oat bran add to the effectiveness of a low-fat diet? 1992 · mixed cooked beans · hypercholesterolaemic men and women | 80 g | 6 weeks | 40 |
| Dietary supplementation with rice bran fermented with Lentinus edodes increases interferon-γ activity without causing adverse effects: a randomized, double-blind, placebo-controlled, parallel-group study 2014 · RBEP group · Adults aged 25–70 years with a white blood cell count of 4,000–8,000 cells/μL and no stated chronic disease | 3 g | 8 weeks | 40 |
| Effects of 3 g of soluble fiber from oats on lipid levels of Asian Indians - a randomized controlled, parallel arm study 2017 · intervention group · Adult men and women aged 20–50 years with total cholesterol ≥200 mg/dL and <240 mg/dL | 70 g | 4 weeks | 40 |
| Effects of isomaltodextrin in postprandial lipid kinetics: Rat study and human randomized crossover study 2018 · IMD diet · Healthy Japanese men and women aged 20 to under 70 years with fasting triglycerides 30 to under 150 mg/dL | 2.5 g | 1 day | 40 |
| Increasing the diversity of dietary fibers in a daily-consumed bread modifies gut microbiota and metabolic profile in subjects at cardiometabolic risk 2022 · Multi-fiber (MF) bread · Adults aged 18–70 with cardiometabolic risk, BMI 25–35 kg/m², and low habitual dietary fiber intake | 16.1 g | 8 weeks | 39 |
| The effects of functional fiber on postprandial glycemia, energy intake, satiety, palatability and gastrointestinal wellbeing: a randomized crossover trial 2014 · fruit fiber bread · University students aged 18–35 years, with normal BMI and fasting blood glucose | 15 g | 1 day | 37 |
| A study to assess the effect of dietary supplementation with soluble fibre (Minolest) on lipid levels in normal subjects with hypercholesterolaemia 1999 · Minolest · People with hypercholesterolaemia; age and sex not reported | 16.5 g | 90 days | 36 |
| Orange Pomace Improves Postprandial Glycemic Responses: An Acute, Randomized, Placebo-Controlled, Double-Blind, Crossover Trial in Overweight Men 2017 · low dose orange pomace (LOP) · Overweight men aged 30–65 years without diabetes | 2.55 g | 1 day | 35 |
| Orange Pomace Improves Postprandial Glycemic Responses: An Acute, Randomized, Placebo-Controlled, Double-Blind, Crossover Trial in Overweight Men 2017 · high dose orange pomace (HOP) · Overweight men aged 30–65 years without diabetes | 5.48 g | 1 day | 35 |
| Effects of grape antioxidant dietary fiber in cardiovascular disease risk factors 2008 · Grape antioxidant dietary fiber group · Non-smoking adults, including normocholesterolemic and hypercholesterolemic adults | 7.5 g | 16 weeks | 34 |
| Chitin-glucan fiber effects on oxidized low-density lipoprotein: a randomized controlled trial 2013 · CG 4.5 g/day · Generally healthy adults aged 21–70 with elevated LDL-C (3.37–4.92 mmol/L) | 1.5 g | 6 weeks | 34 |
| Chitin-glucan fiber effects on oxidized low-density lipoprotein: a randomized controlled trial 2013 · CG 1.5 g/day · Generally healthy adults aged 21–70 with elevated LDL-C (3.37–4.92 mmol/L) | 501 mg | 6 weeks | 33 |
| Abundance of gut Prevotella at baseline and metabolic response to barley prebiotics 2019 · barley kernel bread (BKB) intervention · Men and women aged 50–70 years, apparently healthy, with normal to slightly increased BMI and selected for high Prevotella, low Prevotella, or high Prevotella and Bacteroides gut microbiota | 384 g | 3 days | 33 |
| Effects of High-Fiber Biscuits on Lipid and Anthropometric Profile of Patients with Type 2 Diabetes 2020 · caromma biscuit group · Patients with type 2 diabetes mellitus; age and sex not reported | 100 g | 4 weeks | 33 |
| Effects of High-Fiber Biscuits on Lipid and Anthropometric Profile of Patients with Type 2 Diabetes 2020 · temma biscuit group · Patients with type 2 diabetes mellitus; age and sex not reported | 100 g | 4 weeks | 31 |
| Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals 2004 · sc-FOS · Adults of both genders, mean age 45.5 years, with mild hypercholesterolaemia | 10.6 g | 60 days | 30 |
| [Effectiveness of nutritional support for the liver-cell deficiency in the liver cirrhosis] 2009 · principal group · Patients with Child-Pugh type B hepatic cirrhosis and nutritional impairment; age and sex not reported | 7.5 g | 30 days | 30 |
| Okara Improved Blood Glucose Level in Vietnamese with Type 2 Diabetes Mellitus 2019 · intervention group · Vietnamese outpatients with type 2 diabetes mellitus | 6 g | 2 weeks | 30 |
| Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: A randomized controlled trial 2017 · AED · Men and women aged 50–65 with prediabetes and non-alcoholic fatty liver disease; received aerobic exercise plus the diet intervention | 5 g | 258 days | 29 |
| Impact of dietary fiber supplementation on modulating microbiota-host-metabolic axes in obesity 2019 · pea fiber (PF) · Adults with overweight or obesity | 15 g | 12 weeks | 29 |
| The role of soluble fiber intake in patients under highly effective lipid-lowering therapy 2011 · RSV+Fib · Men and women aged 30–75 in primary or secondary prevention of coronary heart disease, receiving lipid-lowering therapy | 44 g | 12 weeks | 28 |
| The role of soluble fiber intake in patients under highly effective lipid-lowering therapy 2011 · SIM/EZE+Fib · Men and women aged 30–75 in primary or secondary prevention of coronary heart disease, receiving lipid-lowering therapy | 44 g | 12 weeks | 28 |
| Soluble Corn Fiber Increases Calcium Absorption Associated with Shifts in the Gut Microbiome: A Randomized Dose-Response Trial in Free-Living Pubertal Females 2016 · 10 g fiber/d from SCF · Healthy adolescent females aged 11–14 years | 10 g | 4 weeks | 28 |
| Soluble Corn Fiber Increases Calcium Absorption Associated with Shifts in the Gut Microbiome: A Randomized Dose-Response Trial in Free-Living Pubertal Females 2016 · 20 g fiber/d from SCF · Healthy adolescent females aged 11–14 years | 20 g | 4 weeks | 28 |
| A High Fiber Cookie Made with Resistant Starch Type 4 Reduces Post-Prandial Glucose and Insulin Responses in Healthy Adults 2017 · fiber cookie · Healthy adults aged 18 years or older | 25 g | 1 day | 28 |
| Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: A randomized controlled trial 2017 · Diet · Men and women aged 50–65 with prediabetes and non-alcoholic fatty liver disease | 5 g | 258 days | 28 |
| Postprandial glucose and insulin response to a high-fiber muffin top containing resistant starch type 4 in healthy adults: a double-blind, randomized, controlled trial 2018 · VERSAFIBE™ 2470 resistant starch muffin top · Healthy adults | 11.6 g | 1 day | 28 |
| Effects of high-fiber oat and wheat cereals on postprandial glucose and lipid responses in healthy men 2007 · oat cereal · healthy men | 5.7 g | 2 weeks | 27 |
| Obesity Does Not Modulate the Glycometabolic Benefit of Insoluble Cereal Fibre in Subjects with Prediabetes-A Stratified Post Hoc Analysis of the Optimal Fibre Trial (OptiFiT) 2019 · NONOBESE fibre group · Adults with impaired glucose tolerance and BMI below 30 kg/m²; age and sex range not specified | 15 g | 1 year | 26 |
| Effect of cocoa bran on low-density lipoprotein oxidation and fecal bulking 2000 · cocoa-bran cereal · Healthy normolipidemic adults; 13 men and 12 women, mean age 37 years | 25 g | 2 weeks | 25 |
| A high intake of dietary fiber influences C-reactive protein and fibrinogen, but not glucose and lipid metabolism, in mildly hypercholesterolemic subjects 2014 · High-fiber (HF) diet · Adults aged about 59 years with mild hypercholesterolemia | 48 g | 5 weeks | 25 |
| The acute effects of inulin and resistant starch on postprandial serum short-chain fatty acids and second-meal glycemic response in lean and overweight humans 2017 · Resistant starch (RS) · Men and non-pregnant, non-lactating women aged 18–65 years; lean (BMI <25) or overweight (BMI ≥25), without diabetes or the listed excluded diseases | 28 g | 1 day | 25 |
| Acute increases in serum colonic short-chain fatty acids elicited by inulin do not increase GLP-1 or PYY responses but may reduce ghrelin in lean and overweight humans 2017 · Resistant starch (RS) · Men and non-pregnant, non-lactating women aged 18–65 years, lean or overweight/obese (BMI 20–35 kg/m²), without the listed diseases | 28 g | 1 day | 25 |
| Effect of hydrolyzed guar fiber on fasting and postprandial satiety and satiety hormones: a double-blind, placebo-controlled trial during controlled weight loss 1998 · fiber · Obese but otherwise healthy females, mean age 46 years, with mean BMI 35 kg/m² | 20 g | 7 days | 25 |
| A diet rich in oat bran improves blood lipids and hemostatic factors, and reduces apparent energy digestibility in young healthy volunteers 2011 · oat bran diet · Healthy adults, mean age 25.2 years; all sexes, with no stated condition | 102 g | 2 weeks | 24 |
| Soluble maize fibre affects short-term calcium absorption in adolescent boys and girls: a randomised controlled trial using dual stable isotopic tracers 2014 · SCF treatment · Boys and girls aged 12–15 years consuming a low-calcium diet | 12 g | 3 weeks | 24 |
| Effect of oat consumption on lipid profiles in hypercholesterolemic adults 2013 · Oatmeal intervention · Men and women aged 30–60 years with hypercholesterolemia | 3 g | 4 weeks | 24 |
| Resistant Starch Bagels Reduce Fasting and Postprandial Insulin in Adults at Risk of Type 2 Diabetes 2016 · RS bagel treatment · Men and women at increased risk of type 2 diabetes; mean age 55.3 years | 25 g | 8 weeks | 24 |
| A proof-of-concept study to evaluate the efficacy and safety of BTI320 on post-prandial hyperglycaemia in Chinese subjects with pre-diabetes 2018 · Low dose BTI320 · Chinese adults aged 18–70 with prediabetes and at least two specified glucose, HbA1c, or diabetes-risk criteria | 12 g | 16 weeks | 24 |
| A proof-of-concept study to evaluate the efficacy and safety of BTI320 on post-prandial hyperglycaemia in Chinese subjects with pre-diabetes 2018 · High dose BTI320 · Chinese adults aged 18–70 with prediabetes and at least two specified glucose, HbA1c, or diabetes-risk criteria | 24 g | 16 weeks | 24 |
| Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index 1998 · high-fiber control (wheat bran) · healthy adults; 12 men and 12 women | 30 g | 2 weeks | 24 |
| Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index 1998 · RS2 · healthy adults; 12 men and 12 women | 30 g | 2 weeks | 24 |
| Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index 1998 · RS3 · healthy adults; 12 men and 12 women | 30 g | 2 weeks | 24 |
| Improvement of the metabolic syndrome profile by soluble fibre - guar gum - in patients with type 2 diabetes: a randomised clinical trial 2013 · intervention group · Adults with type 2 diabetes and metabolic syndrome; mean age 62 years; both sexes | 10 g | 6 weeks | 23 |
| Butyrylated starch increases colonic butyrate concentration but has limited effects on immunity in healthy physically active individuals 2013 · HAMSB · Healthy physically active male and female volunteers; mean age 37.9 years | 40 g | 4 weeks | 23 |
| Improved Plasma Lipids, Anti-Inflammatory Activity, and Microbiome Shifts in Overweight Participants: Two Clinical Studies on Oral Supplementation with Algal Sulfated Polysaccharide 2022 · 4 g dose of extract group (Study 1) · Adults with overweight or obesity, aged 18 years or older; median age 55 years | 4 g | 6 weeks | 23 |
| Selective Influence of Hemp Fiber Ingestion on Post-Exercise Gut Permeability: A Metabolomics-Based Analysis 2025 · High-dose hemp fiber bar · Healthy male and female cyclists aged 18–65 without stated gastrointestinal disease | 20 g | 2 weeks | 23 |
| Selective Influence of Hemp Fiber Ingestion on Post-Exercise Gut Permeability: A Metabolomics-Based Analysis 2025 · Low-dose hemp fiber bar · Healthy male and female cyclists aged 18–65 without stated gastrointestinal disease | 5 g | 2 weeks | 23 |
| Improving Oxidative Stress Through a Wheat Aleurone-Rich Diet: Are Short-Chain Fatty Acids Possible Mediators? 2025 · Wheat Aleurone Diet · Adults with abdominal obesity and at least one additional feature of metabolic syndrome; ages not reported | 9 g | 8 weeks | 23 |
| Microbiota-Dependent Fiber Responses: A Proof-of-Concept Study on Short-Chain Fatty Acid Production in Prevotella- and Bacteroides-Dominated Healthy Individuals 2025 · AX (arabinoxylan) · Healthy adults aged 30–65 with Prevotella- or Bacteroides-dominated gut microbiota | 15 g | 7 days | 22 |
| Acetogenic fibers reduce fasting glucose turnover but not peripheral insulin resistance in metabolic syndrome patients 2010 · Acetogenic fiber treatment · Men with metabolic syndrome | 28 g | 5 weeks | 21 |
| Fiber supplementation influences phylogenetic structure and functional capacity of the human intestinal microbiome: follow-up of a randomized controlled trial 2015 · polydextrose · healthy adult men | 21 g | 3 weeks | 21 |
| Fiber supplementation influences phylogenetic structure and functional capacity of the human intestinal microbiome: follow-up of a randomized controlled trial 2015 · soluble corn fiber (SCF) · healthy adult men | 21 g | 3 weeks | 21 |
| Effects of whole grain rye, with and without resistant starch type 2 supplementation, on glucose tolerance, gut hormones, inflammation and appetite regulation in an 11-14.5 hour perspective; a randomized controlled study in healthy subjects 2017 · RFB + RS · Healthy men and women aged 20–35 years with BMI 19–25 kg/m² and no known metabolic disorders | 12.1 g | 1 day | 21 |
| Effects of whole grain rye, with and without resistant starch type 2 supplementation, on glucose tolerance, gut hormones, inflammation and appetite regulation in an 11-14.5 hour perspective; a randomized controlled study in healthy subjects 2017 · RFB/RKB + RS · Healthy men and women aged 20–35 years with BMI 19–25 kg/m² and no known metabolic disorders | 10.8 g | 1 day | 21 |
| Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial 2017 · Low FODMAP A · Healthy adults aged 18–65 years, both sexes | 3 g | 1 day | 21 |
| Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial 2017 · Low FODMAP B · Healthy adults aged 18–65 years, both sexes | 3 g | 1 day | 21 |
| Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial 2017 · Low FODMAP C · Healthy adults aged 18–65 years, both sexes | 3 g | 1 day | 21 |
| Effect of oat or rice flour on pulse-induced gastrointestinal symptoms and breath hydrogen in subjects sensitive to pulses and controls - a randomised cross-over trial with two parallel groups 2022 · Oat flour meal, sensitive group · Adults aged 18–64, both sexes, with self-reported pulse-related gastrointestinal symptoms; some had IBS | 18.8 g | 4 days | 21 |
| Effect of oat or rice flour on pulse-induced gastrointestinal symptoms and breath hydrogen in subjects sensitive to pulses and controls - a randomised cross-over trial with two parallel groups 2022 · Oat flour meal, control group · Healthy adults aged 18–64, both sexes, reporting no gastrointestinal problems after pulse consumption | 18.8 g | 4 days | 21 |
| Improved Plasma Lipids, Anti-Inflammatory Activity, and Microbiome Shifts in Overweight Participants: Two Clinical Studies on Oral Supplementation with Algal Sulfated Polysaccharide 2022 · 2 g dose of extract group (Study 1) · Adults with overweight or obesity, aged 18 years or older; median age 55 years | 2 g | 6 weeks | 21 |
| Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects 2010 · fibre group · Hyperinsulinaemic adults with fasting plasma insulin ≥40 pmol/l | 24 g | 1 year | 20 |
| Semisolid meal enriched in oat bran decreases plasma glucose and insulin levels, but does not change gastrointestinal peptide responses or short-term appetite in healthy subjects 2011 · pudding with 10 g wheat bran DF · Healthy, normal-weight adults aged 23.3 ± 0.85 years; 5 male and 15 female | 10 g | 1 day | 20 |
| Semisolid meal enriched in oat bran decreases plasma glucose and insulin levels, but does not change gastrointestinal peptide responses or short-term appetite in healthy subjects 2011 · pudding with 10 g oat bran DF · Healthy, normal-weight adults aged 23.3 ± 0.85 years; 5 male and 15 female | 10 g | 1 day | 20 |
| 454 pyrosequencing reveals a shift in fecal microbiota of healthy adult men consuming polydextrose or soluble corn fiber 2012 · polydextrose (PDX) · healthy adult men | 21 g | 3 weeks | 20 |
| 454 pyrosequencing reveals a shift in fecal microbiota of healthy adult men consuming polydextrose or soluble corn fiber 2012 · soluble corn fiber (SCF) · healthy adult men | 21 g | 3 weeks | 20 |
| Effects of supplementation with nondigestible carbohydrates on fecal calprotectin and on epigenetic regulation of SFRP1 expression in the large-bowel mucosa of healthy individuals 2017 · Polydextrose group · Healthy adults aged 30–80 years | 12 g | 50 days | 20 |
| Resistant starch supplementation increases crypt cell proliferative state in the rectal mucosa of older healthy participants 2020 · B (polydextrose only) · Healthy adults aged 33–80 years; mean age 58 years | 12 g | 50 days | 20 |
| Metabolic and satiating effects and consumer acceptance of a fibre-enriched Leberkas meal: a randomized cross-over trial 2021 · Fibre-enriched Leberkas meal · Middle-aged healthy adults; 10 men and 10 women | 19.2 g | 1 day | 20 |
| Effects of a Rice Bran Dietary Intervention on the Composition of the Intestinal Microbiota of Adults with a High Risk of Colorectal Cancer: A Pilot Randomised-Controlled Trial 2021 · intervention group · Chinese adults aged 50 years or older at high risk of colorectal cancer | 30 g | 24 weeks | 20 |
| Detection of changes in regional colonic fermentation in response to supplementing a low FODMAP diet with dietary fibres by hydrogen concentrations, but not by luminal pH 2023 · Sugarcane diet · Adults aged 19–61 with irritable bowel syndrome (IBS), 19 of 20 participants were female | 10 g | 2 weeks | 20 |
| Daily profiles of plasma short-chain fatty acids after the intake of three different cereal fibers: a randomized controlled study 2025 · arabinoxylan (AX) · Overweight or obese adults aged 30–75 years | 11 g | 1 day | 20 |
| Daily profiles of plasma short-chain fatty acids after the intake of three different cereal fibers: a randomized controlled study 2025 · wheat bran · Overweight or obese adults aged 30–75 years | 11 g | 1 day | 20 |
| Daily profiles of plasma short-chain fatty acids after the intake of three different cereal fibers: a randomized controlled study 2025 · cellulose · Overweight or obese adults aged 30–75 years | 11 g | 1 day | 20 |
| Long-term responses of women to indole-3-carbinol or a high fiber diet 1994 · arm 2 · women; age range and health condition not stated | 20 g | 90 days | 20 |
| Lower serum oestrogen concentrations associated with faster intestinal transit 1997 · Wheat bran · Healthy premenopausal omnivorous women with regular menstrual cycles | 19.8 g | — | 20 |
| Fecal bile acid concentrations in a subpopulation of the wheat bran fiber colon polyp trial 2003 · low fiber (2.0 g/day) intervention group · People enrolled in a Phase III trial for prevention of adenomatous polyp recurrence | 2 g | 876 days | 19 |
| Postprandial hyperglycemia in patients with type 2 diabetes is reduced by raw insoluble fiber: A randomized trial 2024 · raw wheat bran (RWB) · Men with type 2 diabetes mellitus; age range not reported | 5.8 g | 1 day | 19 |
| Effect of an oat bran-rich supplement on the metabolic profile of overweight premenopausal women 2005 · treatment group · Overweight premenopausal women aged 22–53 years | 28 g | 4 weeks | 18 |
| L-rhamnose and lactulose decrease serum triacylglycerols and their rates of synthesis, but do not affect serum cholesterol concentrations in men 2006 · Lactulose · Men; age range and health condition not stated | 25 g | 4 weeks | 18 |
| A randomised clinical trial to evaluate the effects of Plantago ovata husk in Parkinson patients: changes in levodopa pharmacokinetics and biochemical parameters 2014 · Treatment A (Plantago ovata husk) · Adults aged 60–80 with idiopathic Parkinson disease whose symptoms were controlled with oral levodopa/carbidopa | 10.5 g | 2 weeks | 18 |
| Ingestion of Helianthus tuberosus at Breakfast Rather Than at Dinner Is More Effective for Suppressing Glucose Levels and Improving the Intestinal Microbiota in Older Adults 2020 · morning intake group (MG) · Healthy adults aged 65 years or older; men and women; no diagnosed diabetes, dyslipidemia, or sleep apnea | 5 g | 7 days | 18 |
| Gut-microbiota-targeted diets modulate human immune status 2021 · high-fiber diet · Generally healthy adults aged 18 years or older; mean age about 52 years; predominantly women | 20 g | 10 weeks | 18 |
| Effects of supplementation with nondigestible carbohydrates on fecal calprotectin and on epigenetic regulation of SFRP1 expression in the large-bowel mucosa of healthy individuals 2017 · RS group · Healthy adults aged 30–80 years | 23 g | 50 days | 17 |
| Resistant starch supplementation increases crypt cell proliferative state in the rectal mucosa of older healthy participants 2020 · C (resistant starch only) · Healthy adults aged 42–67 years; mean age 53 years | 23 g | 50 days | 17 |
| Ingestion of Helianthus tuberosus at Breakfast Rather Than at Dinner Is More Effective for Suppressing Glucose Levels and Improving the Intestinal Microbiota in Older Adults 2020 · evening intake group (EG) · Healthy adults aged 65 years or older; men and women; no diagnosed diabetes, dyslipidemia, or sleep apnea | 5 g | 7 days | 17 |
| Tapioca Resistant Maltodextrin as a Carbohydrate Source of Oral Nutrition Supplement (ONS) on Metabolic Indicators: A Clinical Trial 2022 · TRM30 formula (Phase I) · Healthy adults aged 18–55 years, with fasting plasma glucose below 100 mg/dL and BMI below 23.0 kg/m² | 5.4 g | 1 day | 17 |
| The effect of flaxseed and wheat bran consumption on urinary estrogen metabolites in premenopausal women 2000 · 28 g wheat bran · Premenopausal women | 28 g | — | 16 |
| Odd-chain fatty acids as a biomarker for dietary fiber intake: a novel pathway for endogenous production from propionate 2017 · cellulose · 16 healthy individuals; age and sex not stated | 30 g | 7 days | 16 |
| Arabinoxylan fibre improves metabolic control in people with Type II diabetes 2004 · AX diet · People with Type II diabetes; age and sex not specified | 15 g | 5 weeks | 15 |
| Acute effects of pea protein and hull fibre alone and combined on blood glucose, appetite, and food intake in healthy young men--a randomized crossover trial 2014 · pea hull fibre · Healthy young men | 7 g | 1 day | 15 |
| Effects of supplemented isoenergetic diets varying in cereal fiber and protein content on the bile acid metabolic signature and relation to insulin resistance 2018 · HCF · Overweight or obese adults with abdominal obesity and at least one additional metabolic-syndrome feature, without diabetes | 30 g | 18 weeks | 15 |
| Chitin-glucan supplementation improved postprandial metabolism and altered gut microbiota in subjects at cardiometabolic risk in a randomized trial 2022 · chitin-glucan (CG) · Adults aged 30–65 with cardiometabolic risk, overweight or obesity, abdominal obesity, and daily fiber intake below 25 g | 4.5 g | 3 weeks | 15 |
| Arabinoxylan fiber, a byproduct of wheat flour processing, reduces the postprandial glucose response in normoglycemic subjects 2000 · 6 g AX-rich fiber breakfast · 14 healthy subjects | 6 g | 1 day | 14 |
| Arabinoxylan fiber, a byproduct of wheat flour processing, reduces the postprandial glucose response in normoglycemic subjects 2000 · 12 g AX-rich fiber breakfast · 14 healthy subjects | 12 g | 1 day | 14 |
| Soluble corn fiber increases bone calcium retention in postmenopausal women in a dose-dependent manner: a randomized crossover trial 2016 · 10 g fiber from SCF/d · Healthy postmenopausal women | 10 g | 50 days | 14 |
| Soluble corn fiber increases bone calcium retention in postmenopausal women in a dose-dependent manner: a randomized crossover trial 2016 · 20 g fiber from SCF/d · Healthy postmenopausal women | 20 g | 50 days | 14 |
| Choline Metabolites, Hydroxybutyrate and HDL after Dietary Fiber Supplementation in Overweight/Obese Hypertensive Women: A Metabolomic Study 2021 · fiber supplementation · Women aged 20–50 years with overweight or obesity and primary hypertension | 12 g | 8 weeks | 14 |
| Fatty Acids and Eicosanoids Change during High-Fiber Diet in NAFLD Patients-Randomized Control Trials (RCT) 2022 · 12 g fiber group · Adults older than 18 years with NAFLD | 12 g | 8 weeks | 14 |
| Fatty Acids and Eicosanoids Change during High-Fiber Diet in NAFLD Patients-Randomized Control Trials (RCT) 2022 · 24 g fiber group · Adults older than 18 years with NAFLD | 24 g | 8 weeks | 14 |
| Effects of non-digestible carbohydrates on gut microbiota and microbial metabolites: a randomised, controlled dietary intervention in healthy individuals 2024 · PD · Healthy adults; mean age across groups 53 years, 55% female; most participants had overweight or obesity | 12 g | 50 days | 14 |
| Full-fat rice bran and oat bran similarly reduce hypercholesterolemia in humans 1998 · full-fat rice bran product · Adults with moderate hypercholesterolemia who were nonsmokers and nonobese | 84 g | 6 weeks | 14 |
| Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus 2000 · Moderate-fiber (ADA) diet · 13 patients with type 2 diabetes mellitus; age and sex not reported | 24 g | 6 weeks | 13 |
| Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus 2000 · High-fiber diet · 13 patients with type 2 diabetes mellitus; age and sex not reported | 50 g | 6 weeks | 13 |
| Metabolic effects and clinical value of beet fiber treatment in NIDDM patients 1991 · beet fiber period · Patients with non-insulin-dependent diabetes mellitus: five treated with diet alone and eight treated with diet and sulphonylurea; age and sex not reported | 16 g | — | 13 |
| Hydroxypropylmethylcellulose lowers cholesterol in statin-treated men and women with primary hypercholesterolemia 2009 · HPMC · Men and women with primary hypercholesterolemia receiving stable-dose statin therapy; mean age 58.6 years | 5 g | 4 weeks | 13 |
| The influence of dietary fibre source and gender on the postprandial glucose and lipid response in healthy subjects 2009 · Oat powder meal · Healthy men and women aged 20–28 years | 2.7 g | 1 day | 13 |
| The influence of dietary fibre source and gender on the postprandial glucose and lipid response in healthy subjects 2009 · Rye bran meal · Healthy men and women aged 20–28 years | 1.7 g | 1 day | 13 |
| The influence of dietary fibre source and gender on the postprandial glucose and lipid response in healthy subjects 2009 · Sugar beet fibre meal · Healthy men and women aged 20–28 years | 5 g | 1 day | 13 |
| Persimmon fruit tannin-rich fiber reduces cholesterol levels in humans 2013 · low-dose group · People with plasma total cholesterol levels of 180–259 mg/dl; age and sex not reported | 9 g | 12 weeks | 13 |
| Persimmon fruit tannin-rich fiber reduces cholesterol levels in humans 2013 · high-dose group · People with plasma total cholesterol levels of 180–259 mg/dl; age and sex not reported | 15 g | 12 weeks | 13 |
| Butyrylated starch intake can prevent red meat-induced O6-methyl-2-deoxyguanosine adducts in human rectal tissue: a randomised clinical trial 2015 · HRM+HAMSB diet · Healthy adults; mean age about 63 years; no active bowel disease | 40 g | 4 weeks | 13 |
| Efficacy of different fibres and flour mixes in South-Asian flatbreads for reducing post-prandial glucose responses in healthy adults 2017 · 83 g HFF + 15 g CPF + 2 g GG · Apparently healthy adults; mean age 37 ± 9 years; 3 men and 35 women among completers | 2 g | 1 day | 13 |
| Efficacy of different fibres and flour mixes in South-Asian flatbreads for reducing post-prandial glucose responses in healthy adults 2017 · 94 g HFF + 6 g GG · Apparently healthy adults; mean age 37 ± 9 years; 3 men and 35 women among completers | 6 g | 1 day | 13 |
| Full-fat rice bran and oat bran similarly reduce hypercholesterolemia in humans 1998 · oat bran product · Adults with moderate hypercholesterolemia who were nonsmokers and nonobese | 84 g | 6 weeks | 13 |
| Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects 1999 · fructo-oligosaccharides (FOS) · Apparently healthy men, mean age 23 years | 15 g | 3 weeks | 12 |
| Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects 1999 · galacto-oligosaccharides (GOS) · Apparently healthy men, mean age 23 years | 15 g | 3 weeks | 12 |
| Hydroxypropylmethylcellulose significantly lowers blood cholesterol in mildly hypercholesterolemic human subjects 2009 · medium-viscosity HPMC (trial one) · mildly hypercholesterolemic adults; 8 women and 4 men; ages not reported | 15 g | 7 days | 12 |
| Hydroxypropylmethylcellulose significantly lowers blood cholesterol in mildly hypercholesterolemic human subjects 2009 · high-viscosity HPMC (trial one) · mildly hypercholesterolemic adults; 8 women and 4 men; ages not reported | 15 g | 7 days | 12 |
| Hydroxypropylmethylcellulose significantly lowers blood cholesterol in mildly hypercholesterolemic human subjects 2009 · ultra-high-viscosity HPMC (trial one) · mildly hypercholesterolemic adults; 8 women and 4 men; ages not reported | 15 g | 7 days | 12 |
| Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)-beta-glycan consumption in overweight humans 2009 · BDG · Overweight and obese humans with moderately increased C-reactive protein levels | 1.5 g | 4 weeks | 12 |
| Idiopathic reactive hypoglycaemia - prevalence and effect of fibre on glucose excursions 2010 · fibre diet-supplementation · Adults with idiopathic reactive hypoglycaemia; age 56 ± 8 years, 6 females | 20 g | 2 weeks | 12 |
| Effects of alpha-glucosidase inhibition and viscous fibre on diabetic control and postprandial gut hormone responses 1990 · Guar granules alone · Adults with type 2 diabetes treated with sulphonylureas | 15 g | 2 weeks | 12 |
| Effects of alpha-glucosidase inhibition and viscous fibre on diabetic control and postprandial gut hormone responses 1990 · Combined BAY m1099 and guar granules · Adults with type 2 diabetes treated with sulphonylureas | 15 g | 2 weeks | 12 |
| Oat-bran cereal lowers serum total and LDL cholesterol in hypercholesterolemic men 1990 · oat-bran cereal diet · men with undesirably high serum total-cholesterol concentrations | 25 g | 2 weeks | 12 |
| Ultrahigh-viscosity hydroxypropylmethylcellulose blunts postprandial glucose after a breakfast meal in women 2012 · UHV-HPMC · Healthy adult women | 4 g | 1 day | 12 |
| Randomized clinical trial in healthy individuals on the effect of viscous fiber blend on glucose tolerance when incorporated in capsules or into the carbohydrate or fat component of the meal 2014 · 1 g VFB baked into white bread · Healthy adults, mean age 36 years, both sexes; no condition stated | 1 g | 1 day | 12 |
| Randomized clinical trial in healthy individuals on the effect of viscous fiber blend on glucose tolerance when incorporated in capsules or into the carbohydrate or fat component of the meal 2014 · 2 g VFB baked into white bread · Healthy adults, mean age 36 years, both sexes; no condition stated | 2 g | 1 day | 12 |
| Randomized clinical trial in healthy individuals on the effect of viscous fiber blend on glucose tolerance when incorporated in capsules or into the carbohydrate or fat component of the meal 2014 · 4 g VFB baked into white bread · Healthy adults, mean age 36 years, both sexes; no condition stated | 4 g | 1 day | 12 |
| Randomized clinical trial in healthy individuals on the effect of viscous fiber blend on glucose tolerance when incorporated in capsules or into the carbohydrate or fat component of the meal 2014 · 1 g VFB mixed with margarine · Healthy adults, mean age 36 years, both sexes; no condition stated | 1 g | 1 day | 12 |
| Randomized clinical trial in healthy individuals on the effect of viscous fiber blend on glucose tolerance when incorporated in capsules or into the carbohydrate or fat component of the meal 2014 · 2 g VFB mixed with margarine · Healthy adults, mean age 36 years, both sexes; no condition stated | 2 g | 1 day | 12 |
| Randomized clinical trial in healthy individuals on the effect of viscous fiber blend on glucose tolerance when incorporated in capsules or into the carbohydrate or fat component of the meal 2014 · 4 g VFB mixed with margarine · Healthy adults, mean age 36 years, both sexes; no condition stated | 4 g | 1 day | 12 |
| Efficacy of different fibres and flour mixes in South-Asian flatbreads for reducing post-prandial glucose responses in healthy adults 2017 · 98 g HFF + 2 g GG · Apparently healthy adults; mean age 37 ± 9 years; 3 men and 35 women among completers | 2 g | 1 day | 12 |
| A New Dietary Fiber Can Enhance Satiety and Reduce Postprandial Blood Glucose in Healthy Adults: A Randomized Cross-Over Trial 2023 · RPG powder experimental group (Powder) · Healthy adults aged 18–40 years; five women and seven men; no stated disease | 6 g | 1 day | 12 |
| Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance 2007 · arabinoxylan (AX) supplement · Adults aged 55.5 years with impaired glucose tolerance; 7 women and 4 men | 15 g | 6 weeks | 11 |
| A study of the effect of diet on glycosylated haemoglobin and albumin levels and glucose tolerance in normal subjects 1990 · high-soluble-fibre/low-glucose diet · 11 non-diabetic adults, 7 men and 4 women; mean age 26.5 years | 15 g | 6 weeks | 11 |
| Efficacy of different fibres and flour mixes in South-Asian flatbreads for reducing post-prandial glucose responses in healthy adults 2017 · 81 g HFF + 15 g CPF + 4 g GG · Apparently healthy adults; mean age 37 ± 9 years; 3 men and 35 women among completers | 4 g | 1 day | 11 |
| Efficacy of different fibres and flour mixes in South-Asian flatbreads for reducing post-prandial glucose responses in healthy adults 2017 · 86 g HFF + 10 g CPF + 4 g GG · Apparently healthy adults; mean age 37 ± 9 years; 3 men and 35 women among completers | 4 g | 1 day | 11 |
| Efficacy of different fibres and flour mixes in South-Asian flatbreads for reducing post-prandial glucose responses in healthy adults 2017 · 88 g HFF + 10 g CPF + 2 g GG · Apparently healthy adults; mean age 37 ± 9 years; 3 men and 35 women among completers | 2 g | 1 day | 11 |
| Resistant starch lowers postprandial glucose and leptin in overweight adults consuming a moderate-to-high-fat diet: a randomized-controlled trial 2017 · HAM-RS2 group · Adults aged 18–50 with BMI ≥28 who were healthy, overweight, sedentary, and normoglycemic | 30 g | 6 weeks | 11 |
| Effects of non-digestible carbohydrates on gut microbiota and microbial metabolites: a randomised, controlled dietary intervention in healthy individuals 2024 · RS · Healthy adults; mean age across groups 53 years, 55% female; most participants had overweight or obesity | 23 g | 50 days | 11 |
| Carbohydrate availability of arroz caldo with lambda-carrageenan 1999 · Experimental arroz caldo · Ten normal fasting subjects; age and sex not reported | 14.8 g | 1 day | 10 |
| Long-term double-blind study on the influence of dietary fibres on faecal bile acid excretion in juvenile ulcerative colitis 1992 · wheat fibre · 10 patients with juvenile ulcerative colitis in remission, orally treated with sulphasalazine; age and sex not reported | 16 g | 26 weeks | 10 |
| Randomised controlled short-term intervention pilot study on rye bran bread in prostate cancer 2003 · rye bran bread group · Men with conservatively treated prostate cancer | 295 g | 3 weeks | 10 |
| Dietary supplementation of different doses of NUTRIOSE FB, a fermentable dextrin, alters the activity of faecal enzymes in healthy men 2005 · 10 g/day NUTRIOSE FB · Healthy men, mean age 31.7 years; no diagnosed condition stated | 10 g | 7 days | 10 |
| Dietary supplementation of different doses of NUTRIOSE FB, a fermentable dextrin, alters the activity of faecal enzymes in healthy men 2005 · 30 g/day NUTRIOSE FB · Healthy men, mean age 31.7 years; no diagnosed condition stated | 30 g | 7 days | 10 |
| Dietary supplementation of different doses of NUTRIOSE FB, a fermentable dextrin, alters the activity of faecal enzymes in healthy men 2005 · 60 g/day NUTRIOSE FB · Healthy men, mean age 31.7 years; no diagnosed condition stated | 60 g | 7 days | 10 |
| Dietary supplementation of different doses of NUTRIOSE FB, a fermentable dextrin, alters the activity of faecal enzymes in healthy men 2005 · 15 g/day NUTRIOSE FB · Healthy men, mean age 31.7 years; no diagnosed condition stated | 15 g | 7 days | 10 |
| Dietary supplementation of different doses of NUTRIOSE FB, a fermentable dextrin, alters the activity of faecal enzymes in healthy men 2005 · 45 g/day NUTRIOSE FB · Healthy men, mean age 31.7 years; no diagnosed condition stated | 45 g | 7 days | 10 |
| Dietary supplementation of different doses of NUTRIOSE FB, a fermentable dextrin, alters the activity of faecal enzymes in healthy men 2005 · 80 g/day NUTRIOSE FB · Healthy men, mean age 31.7 years; no diagnosed condition stated | 80 g | 7 days | 10 |
| Bioavailability of phenolic antioxidants associated with dietary fiber: plasma antioxidant capacity after acute and long-term intake in humans 2009 · Acute intake group · Healthy human volunteers; age and sex not reported | 15 g | 1 day | 10 |
| Reduction of postprandial glycemia by the novel viscous polysaccharide PGX, in a dose-dependent manner, independent of food form 2010 · 2.5 g NVP with glucose drink · Healthy adults, mean age 35.6 years, 5 men and 5 women | 2.5 g | 1 day | 10 |
| Reduction of postprandial glycemia by the novel viscous polysaccharide PGX, in a dose-dependent manner, independent of food form 2010 · 5 g NVP with glucose drink · Healthy adults, mean age 35.6 years, 5 men and 5 women | 5 g | 1 day | 10 |
| Reduction of postprandial glycemia by the novel viscous polysaccharide PGX, in a dose-dependent manner, independent of food form 2010 · 7.5 g NVP with glucose drink · Healthy adults, mean age 35.6 years, 5 men and 5 women | 7.5 g | 1 day | 10 |
| Reduction of postprandial glycemia by the novel viscous polysaccharide PGX, in a dose-dependent manner, independent of food form 2010 · 2.5 g NVP with white bread and margarine · Healthy adults, mean age 33.5 years, 3 men and 7 women | 2.5 g | 1 day | 10 |
| Reduction of postprandial glycemia by the novel viscous polysaccharide PGX, in a dose-dependent manner, independent of food form 2010 · 5 g NVP with white bread and margarine · Healthy adults, mean age 33.5 years, 3 men and 7 women | 5 g | 1 day | 10 |
| Reduction of postprandial glycemia by the novel viscous polysaccharide PGX, in a dose-dependent manner, independent of food form 2010 · 7.5 g NVP with white bread and margarine · Healthy adults, mean age 33.5 years, 3 men and 7 women | 7.5 g | 1 day | 10 |
| Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia 2010 · Study 1: 2.5 g PGX granules · Healthy adults, age 20.3–29.2 years, men and women, without a stated condition | 2.5 g | 1 day | 10 |
| Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia 2010 · Study 1: 5 g PGX granules · Healthy adults, age 20.3–29.2 years, men and women, without a stated condition | 5 g | 1 day | 10 |
| Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia 2010 · Study 1: 7.5 g PGX granules · Healthy adults, age 20.3–29.2 years, men and women, without a stated condition | 7.5 g | 1 day | 10 |
| Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia 2010 · Study 2: PGX granules at −60 min · Healthy adults, age 20.3–29.2 years, men and women, without a stated condition | 5 g | 1 day | 10 |
| Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia 2010 · Study 2: PGX granules at −45 min · Healthy adults, age 20.3–29.2 years, men and women, without a stated condition | 5 g | 1 day | 10 |
| Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia 2010 · Study 2: PGX granules at −30 min · Healthy adults, age 20.3–29.2 years, men and women, without a stated condition | 5 g | 1 day | 10 |
| Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia 2010 · Study 2: PGX granules at −15 min · Healthy adults, age 20.3–29.2 years, men and women, without a stated condition | 5 g | 1 day | 10 |
| Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia 2010 · Study 2: PGX granules at 0 min · Healthy adults, age 20.3–29.2 years, men and women, without a stated condition | 5 g | 1 day | 10 |
| Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia 2010 · Study 2: PGX granules at +15 min · Healthy adults, age 20.3–29.2 years, men and women, without a stated condition | 5 g | 1 day | 10 |
| Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia 2010 · Study 2: PGX capsules at −60 min · Healthy adults, age 20.3–29.2 years, men and women, without a stated condition | 5 g | 1 day | 10 |
| Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia 2010 · Study 2: PGX capsules at −45 min · Healthy adults, age 20.3–29.2 years, men and women, without a stated condition | 5 g | 1 day | 10 |
| Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia 2010 · Study 2: PGX capsules at −30 min · Healthy adults, age 20.3–29.2 years, men and women, without a stated condition | 5 g | 1 day | 10 |
| Regulation of GIP and Ghrelin in Healthy Subjects Fed on Sun-Dried Raisins: A Pilot Study with a Crossover Trial Design 2017 · raisin trial · healthy normal-weight subjects | 74 g | 1 day | 10 |
| Effect of Fibre-Enriched Orange Juice on Postprandial Glycaemic Response and Satiety in Healthy Individuals: An Acute, Randomised, Placebo-Controlled, Double-Blind, Crossover Study 2019 · fibre-enriched orange juice group · Healthy adults aged 18–45 years, men and women, with BMI 20–25 kg/m² | 3.5 g | 1 day | 10 |
| The Short-Term Effects and Tolerability of Low-Viscosity Soluble Fibre on Gastroparesis Patients: A Pilot Clinical Intervention Study 2021 · PHGG (test fibre 1) · Adult women with mild-to-moderate idiopathic or diabetic gastroparesis; ages 18 years or older | 10 g | 1 day | 10 |
| The Short-Term Effects and Tolerability of Low-Viscosity Soluble Fibre on Gastroparesis Patients: A Pilot Clinical Intervention Study 2021 · Gum Arabic (test fibre 2) · Adult women with mild-to-moderate idiopathic or diabetic gastroparesis; ages 18 years or older | 10 g | 1 day | 10 |
| Safety, tolerability, and preliminary effects of cricket chitin for adults with IBS: a double-blind randomized crossover pilot trial 2025 · Cricket-derived chitin · Adults diagnosed with IBS | 4 g | 30 days | 10 |
| High-dose Dietary Fibre Supplementation Enhances the Gut Microbiome, Health, and Athletic Performance of College Basketball Players 2025 · high-dose group (HDG) · Male college basketball players aged 17–25 years | 6.84 g | 8 weeks | 10 |
| High-dose Dietary Fibre Supplementation Enhances the Gut Microbiome, Health, and Athletic Performance of College Basketball Players 2025 · low-dose group (LDG) · Male college basketball players aged 17–25 years | 3.24 g | 8 weeks | 10 |
| Dietary pectin influences fibrin network structure in hypercholesterolaemic subjects 1997 · pectin supplement · Male hyperlipidaemic volunteers | 15 g | 4 weeks | 10 |
| Fermentable carbohydrate supplementation alters nitrogen excretion in chronic renal failure 2006 · fermentable carbohydrate · Patients with chronic renal failure; age and sex not reported | 40 g | 5 weeks | 9 |
| Dietary fiber decreases colonic epithelial cell proliferation and protein synthetic rates in human subjects 2006 · Western diet supplemented with wheat bran · Nine healthy volunteers | 24 g | — | 9 |
| Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer 2010 · low fat diet group · Men with newly diagnosed, untreated prostate cancer; age range not stated | 35 g | 4 weeks | 9 |
| Effects of a gel forming dietary fiber, guar gum, on the absorption of glibenclamide and metabolic control and serum lipids in patients with non-insulin-dependent (type 2) diabetes 1990 · guar gum · Patients with non-insulin-dependent (type 2) diabetes treated with glibenclamide | 15 g | 4 weeks | 9 |
| Effect of unprocessed wheat bran on calciuria and oxaluria in patients with urolithiasis 1990 · Treatment group · Patients with hypercalciuria and a history of urolithiasis; age and sex not reported | 30 g | — | 9 |
| Metabolic studies on the hypolipidaemic effect of guar gum 1990 · guar gum · patients with primary hyperlipidaemia | 30 g | 6 weeks | 9 |
| Efficacy of different fibres and flour mixes in South-Asian flatbreads for reducing post-prandial glucose responses in healthy adults 2017 · 96 g HFF + 4 g GG · Apparently healthy adults; mean age 37 ± 9 years; 3 men and 35 women among completers | 4 g | 1 day | 9 |
| Effect of sodium alginate supplementation on weight management and reproductive hormones in polycystic females 2022 · SA3 · Adult females with PCOS, mean age 25 ± 5 years | 30 mg/kg | 60 days | 9 |
| Effect of sodium alginate supplementation on weight management and reproductive hormones in polycystic females 2022 · SA6 · Adult females with PCOS, mean age 25 ± 5 years | 60 mg/kg | 60 days | 9 |
| Habitual consumption of high-fibre bread fortified with bean hulls increased plasma indole-3-propionic concentration and decreased putrescine and deoxycholic acid faecal concentrations in healthy volunteers 2023 · Bean hull bread roll · Healthy adults aged 18–75 years; four men and five women enrolled, with no chronic health conditions | 40 g | 3 days | 9 |
| Sugar-beet fibre increases cholesterol and reduces bile acid excretion from the small bowel 1993 · 32 g sugar-beet fibre/d · Nine ileostomy subjects; age and sex not reported | 32 g | 3 days | 9 |
| The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study 2004 · Phase 1 short-chain fructooligosaccharides group · Healthy volunteers | 10 g | 7 days | 8 |
| The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study 2004 · Phase 1 soybean oligosaccharides group · Healthy volunteers | 10 g | 7 days | 8 |
| The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study 2004 · Phase 1 galactooligosaccharides group · Healthy volunteers | 10 g | 7 days | 8 |
| The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study 2004 · Phase 1 type III resistant starch group · Healthy volunteers | 10 g | 7 days | 8 |
| The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study 2004 · Phase 1 lactulose group · Healthy volunteers | 10 g | 7 days | 8 |
| The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study 2004 · Phase 1 isomaltooligosaccharides group · Healthy volunteers | 10 g | 7 days | 8 |
| The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study 2004 · Phase 2 short-chain fructooligosaccharides, 2.5 g/d group · Healthy volunteers | 2.5 g | 7 days | 8 |
| The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study 2004 · Phase 2 short-chain fructooligosaccharides, 5.0 g/d group · Healthy volunteers | 5 g | 7 days | 8 |
| The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study 2004 · Phase 2 short-chain fructooligosaccharides, 7.5 g/d group · Healthy volunteers | 7.5 g | 7 days | 8 |
| The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study 2004 · Phase 2 short-chain fructooligosaccharides, 10 g/d group · Healthy volunteers | 10 g | 7 days | 8 |
| The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study 2004 · Phase 2 soybean oligosaccharides, 2.5 g/d group · Healthy volunteers | 2.5 g | 7 days | 8 |
| Prebiotic Potential of a Maize-Based Soluble Fibre and Impact of Dose on the Human Gut Microbiota 2016 · 8 g-SCF group · Healthy adults aged 18–50 years, women and men, without stated disease | 8 g | 2 weeks | 8 |
| Prebiotic Potential of a Maize-Based Soluble Fibre and Impact of Dose on the Human Gut Microbiota 2016 · 14 g-SCF group · Healthy adults aged 18–50 years, women and men, without stated disease | 14 g | 2 weeks | 8 |
| Prebiotic Potential of a Maize-Based Soluble Fibre and Impact of Dose on the Human Gut Microbiota 2016 · 21 g-SCF group · Healthy adults aged 18–50 years, women and men, without stated disease | 21 g | 2 weeks | 8 |
| Oat bran concentrate bread products improve long-term control of diabetes: a pilot study 1996 · oat bran concentrate bread period · Eight men with non-insulin-dependent diabetes (NIDDM), mean age 45 years | 9 g | 12 weeks | 8 |
| Fiber content of diet affects exhaled breath volatiles in fasting and postprandial state in a pilot crossover study 2016 · low-fiber diet · healthy men | 17 g | 7 days | 7 |
| Fiber content of diet affects exhaled breath volatiles in fasting and postprandial state in a pilot crossover study 2016 · high-fiber diet · healthy men | 44 g | 7 days | 7 |
| High fiber diets slow bone turnover in young men but have no effect on efficiency of intestinal calcium absorption 1993 · high fiber period · Young men | 31.3 g | 23 days | 7 |
| Fermentability of an enzymatically modified solubilised potato polysaccharide (SPP) 1998 · Bread made of 180 g wheat flour served with 20 g raw SPP · Seven healthy volunteers; age and sex not specified | 20 g | 1 day | 7 |
| Effects of pea and soybean fibre on postprandial lipaemia and lipoproteins in healthy adults 1993 · pea fibre · Six normolipidaemic adult males | 10 g | 1 day | 6 |
| Effects of pea and soybean fibre on postprandial lipaemia and lipoproteins in healthy adults 1993 · soybean fibre · Six normolipidaemic adult males | 10 g | 1 day | 6 |
| Postprandial lipemia in relation to sterol and fat excretion in ileostomy subjects given oat-bran and wheat test meals 1997 · Oat-bran test meal (OB) · Six ileostomy subjects, three women and three men; age and underlying condition not reported | 16.3 g | 1 day | 6 |
| Studies on the effects of polydextrose intake on physiologic functions in Chinese people 2000 · 4 g polydextrose/day · Chinese subjects; age, sex, and health status not specified | 4 g | — | — |
| Studies on the effects of polydextrose intake on physiologic functions in Chinese people 2000 · 8 g polydextrose/day · Chinese subjects; age, sex, and health status not specified | 8 g | — | — |
| Studies on the effects of polydextrose intake on physiologic functions in Chinese people 2000 · 12 g polydextrose/day · Chinese subjects; age, sex, and health status not specified | 12 g | — | — |
| Do colonic short-chain fatty acids contribute to the long-term adaptation of blood lipids in subjects with type 2 diabetes consuming a high-fiber diet? 2002 · HF diet · People with type 2 diabetes; age and sex not specified | 50 g | 26 weeks | — |
| Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men 2002 · low-GI breakfast (low-GIB) · Men with type 2 diabetes | 3 g | 4 weeks | — |
| Non-digestible oligosaccharides and calcium absorption in girls with adequate calcium intakes 2002 · oligofructose · Girls at or near menarche with adequate calcium intakes | 8 g | 3 weeks | — |
| Effects of a beverage containing an enzymatically induced-viscosity dietary fiber, with or without fructose, on the postprandial glycemic response to a high glycemic index food in humans 2003 · 5 g guar gum · Healthy nondiabetic adults; age and sex ranges not reported | 5 g | 1 day | — |
| Role of water-soluble dietary fiber in the management of elevated plasma cholesterol in healthy subjects 1992 · High-viscosity guar gum, 10 g WSDF/day · Healthy men and women with plasma cholesterol greater than 5.17 mmol/L (greater than 200 mg/dL) | 10 g | 4 weeks | — |
| Influence of two guar preparations on glycosylated hemoglobin, total cholesterol and triglycerides in patients with diabetes mellitus 1992 · GU-052 group · Adults with diabetes mellitus and HbA1 > 10%; age and sex not specified | 12 g | 12 weeks | — |
| Influence of two guar preparations on glycosylated hemoglobin, total cholesterol and triglycerides in patients with diabetes mellitus 1992 · Glucotard group · Adults with diabetes mellitus and HbA1 > 10%; age and sex not specified | 15 g | 12 weeks | — |
| Combining wheat bran with resistant starch has more beneficial effects on fecal indexes than does wheat bran alone 2004 · WB diet · Volunteers with a family history of colorectal cancer; age and sex not reported | 12 g | 3 weeks | — |
| L-Rhamnose increases serum propionate after long-term supplementation, but lactulose does not raise serum acetate 2004 · lactulose · 11 human subjects; age, sex, and health condition not stated | 25 g | 4 weeks | — |
| Randomized, controlled, crossover trial of oat bran in hypercholesterolemic subjects 1991 · oat-bran groups · Men and women aged 20 to 70 years with baseline LDL cholesterol in the 50th to 95th percentile | 56 g | — | — |
| Carob pulp preparation rich in insoluble dietary fiber and polyphenols enhances lipid oxidation and lowers postprandial acylated ghrelin in humans 2006 · 5 g carob fiber · Healthy adults aged 22–62 years | 5 g | 1 day | — |
| Carob pulp preparation rich in insoluble dietary fiber and polyphenols enhances lipid oxidation and lowers postprandial acylated ghrelin in humans 2006 · 10 g carob fiber · Healthy adults aged 22–62 years | 10 g | 1 day | — |
| Carob pulp preparation rich in insoluble dietary fiber and polyphenols enhances lipid oxidation and lowers postprandial acylated ghrelin in humans 2006 · 20 g carob fiber · Healthy adults aged 22–62 years | 20 g | 1 day | — |
| Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level 2007 · fiber-supplemented diet · Adults aged 18–49, including lean normotensive and obese hypertensive participants | 30 g | — | — |
| Suppressive effect of resistant maltodextrin on postprandial blood triacylglycerol elevation 2007 · 5 g resistant maltodextrin · Healthy adult men and women | 5 g | 1 day | — |
| Suppressive effect of resistant maltodextrin on postprandial blood triacylglycerol elevation 2007 · 10 g resistant maltodextrin · Healthy adult men and women | 10 g | 1 day | — |
| Hydroxypropylmethylcellulose significantly lowers blood cholesterol in mildly hypercholesterolemic human subjects 2009 · ultra-high-viscosity HPMC, 5 g/day (trial two) · mildly hypercholesterolemic adults; 20 women and 20 men; ages not reported | 5 g | 8 weeks | — |
| Hydroxypropylmethylcellulose significantly lowers blood cholesterol in mildly hypercholesterolemic human subjects 2009 · ultra-high-viscosity HPMC, 15 g/day (trial two) · mildly hypercholesterolemic adults; 20 women and 20 men; ages not reported | 15 g | 8 weeks | — |
| Hydroxypropylmethylcellulose and methylcellulose consumption reduce postprandial insulinemia in overweight and obese men and women 2008 · 1 g HV-HPMC · Overweight and obese men and women | 1 g | 1 day | — |
| Hydroxypropylmethylcellulose and methylcellulose consumption reduce postprandial insulinemia in overweight and obese men and women 2008 · 2 g HV-HPMC · Overweight and obese men and women | 2 g | 1 day | — |
| Hydroxypropylmethylcellulose and methylcellulose consumption reduce postprandial insulinemia in overweight and obese men and women 2008 · 2 g UHV-HPMC · Overweight and obese men and women | 2 g | 1 day | — |
| Hydroxypropylmethylcellulose and methylcellulose consumption reduce postprandial insulinemia in overweight and obese men and women 2008 · 4 g medium-viscosity MC · Overweight and obese men and women | 4 g | 1 day | — |
| Slowly digestible carbohydrate sources can be used to attenuate the postprandial glycemic response to the ingestion of diabetes-specific enteral formulas 2009 · Formula 1 (isomaltulose) · Patients with type 2 diabetes; age and sex not reported | 4 g | 1 day | — |
| Slowly digestible carbohydrate sources can be used to attenuate the postprandial glycemic response to the ingestion of diabetes-specific enteral formulas 2009 · High-fat diabetes-specific formula · Patients with type 2 diabetes; age and sex not reported | 2.9 g | 1 day | — |
| Slowly digestible carbohydrate sources can be used to attenuate the postprandial glycemic response to the ingestion of diabetes-specific enteral formulas 2009 · Standard formula · Patients with type 2 diabetes; age and sex not reported | 2.8 g | 1 day | — |
| Resistant starch improves insulin sensitivity in metabolic syndrome 2010 · fibre supplement (resistant starch) · Insulin-resistant subjects with metabolic syndrome | 40 g | 12 weeks | — |
| The effect of pre- and probiotics on the colonic ammonia metabolism in humans as measured by lactose-[¹⁵N₂]ureide 2010 · potato fibre (FP) · Healthy adults aged 20–28 years | 30 g | 10 days | — |
| Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets 1990 · low-fat, low-cholesterol diet plus 50 gm/day oat bran (LFLC + OB) · Men and women with hypercholesterolemia (serum cholesterol greater than the 75th percentile) | 50 g | — | — |
| Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets 1990 · 50 gm/day oat bran supplemented diet (OB) · Men and women with hypercholesterolemia (serum cholesterol greater than the 75th percentile) | 50 g | — | — |
| Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets 1990 · 42.5 gm/day processed oat bran (ready-to-eat cereal containing beta-glucan concentrated from oat bran) (POB) · Men and women with hypercholesterolemia (serum cholesterol greater than the 75th percentile) | 42.5 g | — | — |
| Placebo-controlled trial of the effects of guar gum and metformin on fasting blood glucose and serum lipids in obese, type 2 diabetic patients 1990 · guar gum · Obese patients with type 2 diabetes; age and sex not stated | 15 g | 90 days | — |
| Soy cotyledon fiber products reduce plasma lipids 1990 · Soy cotyledon fiber supplementation · Free-living subjects with mildly elevated fasting plasma total cholesterol; age and sex not reported | 20 g | 6 weeks | — |
| Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: a double-blind, randomised, placebo-controlled, cross-over trial 2012 · 10 g WBE/d · Healthy adult volunteers; age range and sex not specified | 10 g | 3 weeks | — |
| Intake of whole apples or clear apple juice has contrasting effects on plasma lipids in healthy volunteers 2013 · apple pomace · 23 healthy volunteers; age range and sex not stated | 22 g | 4 weeks | — |
| Polydextrose and soluble corn fiber increase five-day fecal wet weight in healthy men and women 2013 · polydextrose (PDX) treatment · healthy men and women; age range not reported | 20 g | 10 days | — |
| Polydextrose and soluble corn fiber increase five-day fecal wet weight in healthy men and women 2013 · soluble corn fiber (SCF) treatment · healthy men and women; age range not reported | 20 g | 10 days | — |
| Changes in visceral adiposity and serum cholesterol with a novel viscous polysaccharide in Japanese adults with abdominal obesity 2013 · PGX · Japanese adults with abdominal obesity | 15 g | 14 weeks | — |
| In vitro degradation and fermentation of three dietary fiber sources by human colonic bacteria 2013 · gum arabic (GA) group · Community-living adults with fecal incontinence; mean age 58 years (SD 13); sex distribution not specified for this arm | 16.6 g | 3 weeks | — |
| In vitro degradation and fermentation of three dietary fiber sources by human colonic bacteria 2013 · carboxymethylcellulose (CMC) group · Community-living adults with fecal incontinence; mean age 58 years (SD 13); sex distribution not specified for this arm | 16.2 g | 3 weeks | — |
| Improvement of fasting plasma glucose level after ingesting moderate amount of dietary fiber in Japanese men with mild hyperglycemia and visceral fat obesity 2013 · test food group · Japanese men with mild hyperglycemia and visceral fat accumulation | 7.5 g | 12 weeks | — |
| The effect of α-cyclodextrin on postprandial lipid and glycemic responses to a fat-containing meal 2013 · α-cyclodextrin · healthy adults | 2 g | 1 day | — |
| The metabolizable energy of dietary resistant maltodextrin is variable and alters fecal microbiota composition in adult men 2014 · 25 g/d RM + 25 g of maltodextrin/d · adult men | 25 g | 24 days | — |
| The metabolizable energy of dietary resistant maltodextrin is variable and alters fecal microbiota composition in adult men 2014 · 50 g/d RM + 0 g/d maltodextrin · adult men | 50 g | 24 days | — |
| α-Galacto-oligosaccharides Dose-Dependently Reduce Appetite and Decrease Inflammation in Overweight Adults 2015 · 12 g α-GOS/day, degree of polymerization 2 formulation · Overweight adults aged 18–60 years, BMI 25–28 kg/m²; 50% men and 50% women | 12 g | 2 weeks | — |
| α-Galacto-oligosaccharides Dose-Dependently Reduce Appetite and Decrease Inflammation in Overweight Adults 2015 · 12 g α-GOS/day, degree of polymerization 3 formulation · Overweight adults aged 18–60 years, BMI 25–28 kg/m²; 50% men and 50% women | 12 g | 2 weeks | — |
| α-Galacto-oligosaccharides Dose-Dependently Reduce Appetite and Decrease Inflammation in Overweight Adults 2015 · 12 g α-GOS/day, degree of polymerization 4 formulation · Overweight adults aged 18–60 years, BMI 25–28 kg/m²; 50% men and 50% women | 12 g | 2 weeks | — |
| Effects of oat bran and nutrition counseling on the lipid and glucose profile and anthropometric parameters of hypercholesterolemia patients 2016 · OB Group (OBG) · Men and women with hypercholesterolemia and LDL-c ≥ 130 mg/dL | 40 g | 90 days | — |
| Addition of Orange Pomace to Orange Juice Attenuates the Increases in Peak Glucose and Insulin Concentrations after Sequential Meal Ingestion in Men with Elevated Cardiometabolic Risk 2016 · OJ with 5.5 g added orange pomace fiber (OPF) · Men aged 30–65 years with elevated cardiometabolic risk | 5.5 g | 1 day | — |
| Dietary supplementation with rice bran or navy bean alters gut bacterial metabolism in colorectal cancer survivors 2017 · SRB · Colorectal cancer survivors more than four months after cancer treatment; age and sex not specified | 30 g | 4 weeks | — |
| Dietary supplementation with rice bran or navy bean alters gut bacterial metabolism in colorectal cancer survivors 2017 · NBP · Colorectal cancer survivors more than four months after cancer treatment; age and sex not specified | 35 g | 4 weeks | — |
| In healthy adults, resistant maltodextrin produces a greater change in fecal bifidobacteria counts and increases stool wet weight: a double-blind, randomized, controlled crossover study 2018 · 15 g RMD daily · Healthy adults, mean age 26.3 years; sex and age range not reported | 15 g | 3 weeks | — |
| In healthy adults, resistant maltodextrin produces a greater change in fecal bifidobacteria counts and increases stool wet weight: a double-blind, randomized, controlled crossover study 2018 · 25 g RMD daily · Healthy adults, mean age 26.3 years; sex and age range not reported | 25 g | 3 weeks | — |
| Extrinsic wheat fibre consumption enhances faecal bulk and stool frequency; a randomized controlled trial 2019 · extrinsic wheat fibre-enriched products · healthy male volunteers | 20 g | 10 days | — |
| Arabinoxylan oligosaccharides and polyunsaturated fatty acid effects on gut microbiota and metabolic markers in overweight individuals with signs of metabolic syndrome: A randomized cross-over trial 2020 · AXOS intervention · Overweight individuals with indices of metabolic syndrome | 10.4 g | 4 weeks | — |
| Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial 2019 · Inulin-propionate ester (IPE) · Adults aged 49–65 at screening, men and women with overweight or obesity (BMI 25–40 kg/m²) | 20 g | 6 weeks | — |
| Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial 2019 · Cellulose · Adults aged 49–65 at screening, men and women with overweight or obesity (BMI 25–40 kg/m²) | 20 g | 6 weeks | — |
| Whey Protein Combined with Low Dietary Fiber Improves Lipid Profile in Subjects with Abdominal Obesity: A Randomized, Controlled Trial 2019 · MD-HiFi · Adults aged 40 years or older with abdominal obesity | 30 g | 12 weeks | — |
| Contrasting effects of viscous and particulate fibers on colonic fermentation in vitro and in vivo, and their impact on intestinal water studied by MRI in a randomized trial 2020 · Wheat bran · Healthy volunteers; age and sex not reported | 15 g | 2 days | — |
| Contrasting effects of viscous and particulate fibers on colonic fermentation in vitro and in vivo, and their impact on intestinal water studied by MRI in a randomized trial 2020 · Nopal · Healthy volunteers; age and sex not reported | 15 g | 2 days | — |
| Effects of whey protein and dietary fiber intake on insulin sensitivity, body composition, energy expenditure, blood pressure, and appetite in subjects with abdominal obesity 2021 · maltodextrin with high-fiber cereal products · Adults with abdominal obesity | 30 g | 12 weeks | — |
| Effects of whey protein and dietary fiber intake on insulin sensitivity, body composition, energy expenditure, blood pressure, and appetite in subjects with abdominal obesity 2021 · maltodextrin with low-fiber cereal products · Adults with abdominal obesity | 10 g | 12 weeks | — |
| Diet-Associated Inflammation Modulates Inflammation and WNT Signaling in the Rectal Mucosa, and the Response to Supplementation with Dietary Fiber 2021 · RS · Healthy adults aged 30–80 years; 53% female | 23 g | 50 days | — |
| Diet-Associated Inflammation Modulates Inflammation and WNT Signaling in the Rectal Mucosa, and the Response to Supplementation with Dietary Fiber 2021 · PD · Healthy adults aged 30–80 years; 53% female | 12 g | 50 days | — |
| Colonic Microbiota Profile Characterization of the Responsiveness to Dietary Fibre Treatment in Hypercholesterolemia 2022 · insoluble fibre · Adults aged 37–68 with hypercholesterolemia; both sexes | 19.2 g | 60 days | — |
| Colonic Microbiota Profile Characterization of the Responsiveness to Dietary Fibre Treatment in Hypercholesterolemia 2022 · soluble fibre · Adults aged 37–68 with hypercholesterolemia; both sexes | 19.2 g | 60 days | — |
| Colonic Microbiota Profile Characterization of the Responsiveness to Dietary Fibre Treatment in Hypercholesterolemia 2022 · antioxidant fibre · Adults aged 37–68 with hypercholesterolemia; both sexes | 19.2 g | 60 days | — |
| An inverse association between plasma benzoxazinoid metabolites and PSA after rye intake in men with prostate cancer revealed with a new method 2022 · Refined wheat products with added cellulose derived from cereal straws (WP) · Men aged 73.5 ± 4.6 years with biopsy-proven, low-grade, untreated indolent prostate cancer | 57 g | 6 weeks | — |
| Resistant Maltodextrin Consumption in a Double-Blind, Randomized, Crossover Clinical Trial Induces Specific Changes in Potentially Beneficial Gut Bacteria 2022 · 15 g RMD · Adults aged 18–50 years; volunteers, with no diagnosed condition stated | 15 g | 3 weeks | — |
| Resistant Maltodextrin Consumption in a Double-Blind, Randomized, Crossover Clinical Trial Induces Specific Changes in Potentially Beneficial Gut Bacteria 2022 · 25 g RMD · Adults aged 18–50 years; volunteers, with no diagnosed condition stated | 25 g | 3 weeks | — |
| Effect of unsaturated fat and protein intake on liver fat in people at risk of unhealthy aging: 1-year results of a randomized controlled trial 2023 · Intervention group (IG) · Adults aged 50–80 with at least one risk factor for unhealthy aging | 30 g | 1096 days | — |
| High-fiber diet and rope-skipping benefit cardiometabolic health and modulate gut microbiota in young adults: A randomized controlled trial 2023 · HF group · Young adult undergraduates with low cardiometabolic risk; sex and age range not specified | 20 g | 12 weeks | — |
| Type 3 resistant starch from Canna edulis reduce lipid levels in patients with mild hyperlipidemia through altering gut microbiome: A double- blind randomized controlled trial 2024 · Ce-RS3 · Patients with mild hyperlipidemia; age and sex not reported | 20 g | 12 weeks | — |
| NUTRIOSE® soluble fibre supplementation as an effective dietary strategy to improve glycaemic response 2025 · NUTRIOSE® supplementation · Healthy adults in Singapore, average age 39.9 years, including an overweight group and a genetic risk group; both men and women | 40 g | 8 weeks | — |
| Resistant starch in the diet increases breath hydrogen and serum acetate in human subjects 1995 · High-RS diet · Eight healthy subjects; age and sex not reported | 59.1 g | 1 day | — |
| Resistant starch in the diet increases breath hydrogen and serum acetate in human subjects 1995 · Low-RS diet · Eight healthy subjects; age and sex not reported | 5.2 g | 1 day | — |
| Wheat fibre, lactulose and rectal mucosal proliferation in individuals with a family history of colorectal cancer 1994 · wheat fibre · Individuals at increased risk of colorectal cancer because of a family history of the disease | 10.5 g | 12 weeks | — |
| Wheat fibre, lactulose and rectal mucosal proliferation in individuals with a family history of colorectal cancer 1994 · lactulose · Individuals at increased risk of colorectal cancer because of a family history of the disease | 60 mL | 12 weeks | — |
| Hypocholesterolemic effects of a dietary fiber supplement 1994 · 10 g/d fiber supplement · Patients with mild to moderate hypercholesterolemia | 10 g | 15 weeks | — |
| Hypocholesterolemic effects of a dietary fiber supplement 1994 · 20 g/d fiber supplement · Patients with mild to moderate hypercholesterolemia | 20 g | 15 weeks | — |
| Cholesterol-lowering effect of barley bran flour and oil 1994 · 20 g added cellulose · men and women with hypercholesterolemia, mean age 48.2 years | 20 g | 30 days | — |
| Cholesterol-lowering effect of barley bran flour and oil 1994 · 30 g added barley bran flour · men and women with hypercholesterolemia, mean age 48.2 years | 30 g | 30 days | — |
| The effect of acacia gum and a water-soluble dietary fiber mixture on blood lipids in humans 1993 · WSDF mixture · Hypercholesterolemic adult males and females | 15 g | 4 weeks | — |
| Sex differences in colonic function: a randomised trial 1993 · 10 g wheat bran fibre diet · Adult men and women; no condition stated | 10 g | 23 days | — |
| Sex differences in colonic function: a randomised trial 1993 · 30 g wheat bran fibre diet · Adult men and women; no condition stated | 30 g | 23 days | — |
| Sex differences in colonic function: a randomised trial 1993 · 10 g vegetable fibre diet · Adult men and women; no condition stated | 10 g | 23 days | — |
| Sex differences in colonic function: a randomised trial 1993 · 30 g vegetable fibre diet · Adult men and women; no condition stated | 30 g | 23 days | — |
| Supplementation with gum arabic fiber increases fecal nitrogen excretion and lowers serum urea nitrogen concentration in chronic renal failure patients consuming a low-protein diet 1996 · gum arabic · Chronic renal failure patients consuming a low-protein diet | 50 g | — | — |
| Long-term effects of water-soluble dietary fiber in the management of hypercholesterolemia in healthy men and women 1997 · WSDF mixture · Healthy men and women with moderate hypercholesterolemia consuming their usual fat-modified diets | 15 g | 26 weeks | — |
| Effects of different glycaemic index foods and dietary fibre intake on glycaemic control in type 1 diabetic patients on intensive insulin therapy 1998 · high fibre diet · Nine well-controlled, highly motivated patients with type 1 diabetes on intensive insulin therapy | 15 g | 12 days | — |
| Synbiotic Supplementation Improves Response to Iron Supplementation in Female Athletes during Training 2022 · Daily synbiotic supplement plus iron · Female athletes with low iron status | 5 g | 8 weeks | 9 |
| Gut microbial community and host intestinal gene expression with combined fish oil and soluble corn fiber compared with corn oil and maltodextrin: A randomized crossover trial in healthy older individuals 2025 · SCF + FO · Adults aged 50–75 years described as healthy older individuals | 33 g | 30 days | — |
| Amelioration of intestinal barrier function and reduction of blood lead level in adult women with recurrent spontaneous abortion by a novel product of dietary fiber mixture, Holofood 2023 · Holofood experimental group · Women aged 22–42 with recurrent spontaneous abortion and blood lead concentration greater than 20 µg/L | 30 g | 8 weeks | 48 |
| Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch 2011 · 25 g NSP plus 22 g RS diet · Healthy adults aged 31–66 years, male and female | 47 g | 4 weeks | 46 |
| Postprandial Glycemic and Insulinemic Response by a Brewer's Spent Grain Extract-Based Food Supplement in Subjects with Slightly Impaired Glucose Tolerance: A Monocentric, Randomized, Cross-Over, Double-Blind, Placebo-Controlled Clinical Trial 2022 · BSG extract-based food supplement (treatment A) · Adults aged 18–65 years, either sex, normoglycemic with slightly impaired glucose tolerance and mild insulin resistance | 4.25 g | 1 day | 40 |
| Chitin-glucan fiber effects on oxidized low-density lipoprotein: a randomized controlled trial 2013 · CG 1.5 g/day plus olive extract 135 mg/day · Generally healthy adults aged 21–70 with elevated LDL-C (3.37–4.92 mmol/L) | 501 mg | 6 weeks | 33 |
| Effect of two dietary fibers on satiety and glycemic parameters: a randomized, double-blind, placebo-controlled, exploratory study 2014 · high-dose OFS + P · Men and women aged 18–60 years with BMI 25.0 to <35.0, described as healthy volunteers | 30 g | 3 weeks | 30 |
| Diabetes Therapeutics of Prebiotic Soluble Dietary Fibre and Antioxidant Anthocyanin Supplement in Patients with Type 2 Diabetes: Randomised Placebo-Controlled Clinical Trial 2025 · supplement group (SG) · Adults aged 30–60 years with diagnosed type 2 diabetes | 1.26 g | 60 days | 30 |
| Pesco-Vegetarian Food Components Promote Colonocyte Ferroptosis in Preclinical Mouse Models and a Randomized Crossover Trial in Healthy Human Adults 2026 · SCF+FO · 30 healthy adults | 33 g | 30 days | 30 |
| A randomised, placebo-controlled trial in healthy humans of modified cellulose or psyllium evaluating the role of gelation in altering colonic gas production during inulin co-administration 2026 · methylcellulose (MC) · Healthy adults; median age 27 years (IQR 24–32), 57% female | 15 g | 1 day | 30 |
| Effect of two dietary fibers on satiety and glycemic parameters: a randomized, double-blind, placebo-controlled, exploratory study 2014 · low-dose OFS + P · Men and women aged 18–60 years with BMI 25.0 to <35.0, described as healthy volunteers | 15 g | 3 weeks | 29 |
| Lupin and soya reduce glycaemia acutely in type 2 diabetes 2011 · lupin · Adults with type 2 diabetes; 19 men and 5 women overall | 12.5 g | 1 day | 24 |
| Lupin and soya reduce glycaemia acutely in type 2 diabetes 2011 · soya · Adults with type 2 diabetes; 19 men and 5 women overall | 12.5 g | 1 day | 24 |
| Effect of a low dose whey/guar preload on glycemic control in people with type 2 diabetes--a randomised controlled trial 2014 · active drink (whey protein and guar) · 24 people with prediabetes or moderately well-controlled type 2 diabetes; ages and sex not specified for the full group | 5 g | 5 days | 24 |
| Semisolid meal enriched in oat bran decreases plasma glucose and insulin levels, but does not change gastrointestinal peptide responses or short-term appetite in healthy subjects 2011 · pudding with 5 g wheat bran DF + 5 g oat bran DF · Healthy, normal-weight adults aged 23.3 ± 0.85 years; 5 male and 15 female | 10 g | 1 day | 20 |
| Detection of changes in regional colonic fermentation in response to supplementing a low FODMAP diet with dietary fibres by hydrogen concentrations, but not by luminal pH 2023 · Combination diet · Adults aged 19–61 with irritable bowel syndrome (IBS), 19 of 20 participants were female | 22 g | 2 weeks | 20 |
| Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study 2016 · Healthy-carbohydrate diet (HCD) · Adults aged 39–75 with metabolic syndrome | 104 g | 4 weeks | 19 |
| Effects of supplemented isoenergetic diets varying in cereal fiber and protein content on the bile acid metabolic signature and relation to insulin resistance 2018 · MIX · Overweight or obese adults with abdominal obesity and at least one additional metabolic-syndrome feature, without diabetes | 16 g | 18 weeks | 19 |
| Effects of supplementation with nondigestible carbohydrates on fecal calprotectin and on epigenetic regulation of SFRP1 expression in the large-bowel mucosa of healthy individuals 2017 · Double-intervention group (RS + polydextrose) · Healthy adults aged 30–80 years | 35 g | 50 days | 18 |
| Resistant starch supplementation increases crypt cell proliferative state in the rectal mucosa of older healthy participants 2020 · D (resistant starch and polydextrose) · Healthy adults aged 36–74 years; mean age 50 years | 35 g | 50 days | 18 |
| The effect of flaxseed and wheat bran consumption on urinary estrogen metabolites in premenopausal women 2000 · 10 g flaxseed plus 28 g wheat bran · Premenopausal women | 28 g | — | 16 |
| Effects of non-digestible carbohydrates on gut microbiota and microbial metabolites: a randomised, controlled dietary intervention in healthy individuals 2024 · RS + PD · Healthy adults; mean age across groups 53 years, 55% female; most participants had overweight or obesity | 35 g | 50 days | 16 |
| Acute effects of pea protein and hull fibre alone and combined on blood glucose, appetite, and food intake in healthy young men--a randomized crossover trial 2014 · pea protein plus hull fibre · Healthy young men | 7 g | 1 day | 15 |
| [Multi-strain probiotic combined with dietary fiber is an effective factor in the nutritional support of immunity in athletes] 2024 · main group · Male basketball athletes aged 18 to 24 years | 40 g | 23 days | 15 |
| Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection 2012 · Synbiotic · Adult women with HIV-1 infection taking antiretroviral medication and with blood CD4 count >200 cells/μl | 2.5 g | 4 weeks | 14 |
| The influence of dietary fibre source and gender on the postprandial glucose and lipid response in healthy subjects 2009 · Mixed fibre meal · Healthy men and women aged 20–28 years | 5.1 g | 1 day | 13 |
| Glycemic responses to sweetened dried and raw cranberries in humans with type 2 diabetes 2010 · sweetened dried cranberries with less sugar (SDC-LS) · Adults with type 2 diabetes; age and sex not reported | 10 g | 1 day | 13 |
| Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection 2012 · Fiber-only · Adult women with HIV-1 infection taking antiretroviral medication and with blood CD4 count >200 cells/μl | 2.5 g | 4 weeks | 13 |
| Lowering effects of a preparation containing fibres and lactulose on glucose and insulin levels in obesity 1994 · Fiberlac biscuits · Obese patients; age and sex not reported | 10 g | — | 10 |
| Effect of lactulose on carbohydrate metabolism and diabetes mellitus 1997 · Dietary fibre and lactulose biscuits · 10 obese patients; age and sex not reported | 10 g | 1 day | 10 |
| Oat bran rapidly increases bile acid excretion and bile acid synthesis: an ileostomy study 2007 · native beta-glucans · Nine volunteers with conventional ileostomies | 75 g | 3 days | 9 |
| Oat bran rapidly increases bile acid excretion and bile acid synthesis: an ileostomy study 2007 · hydrolysed beta-glucans · Nine volunteers with conventional ileostomies | 75 g | 3 days | 9 |
| Chronic oat bran intake alters postprandial lipemia and lipoproteins in healthy adults 1995 · OB-A (oat bran-adaptation) · Six normolipidemic men | 40 g | 2 weeks | 6 |
| Non-digestible oligosaccharides and calcium absorption in girls with adequate calcium intakes 2002 · inulin+oligofructose mixture · Girls at or near menarche with adequate calcium intakes | 8 g | 3 weeks | — |
| Effects of a beverage containing an enzymatically induced-viscosity dietary fiber, with or without fructose, on the postprandial glycemic response to a high glycemic index food in humans 2003 · 5 g guar gum + 5 g fructose · Healthy nondiabetic adults; age and sex ranges not reported | 5 g | 1 day | — |
| Role of water-soluble dietary fiber in the management of elevated plasma cholesterol in healthy subjects 1992 · WSDF mixture, 17.2 g/day, 56% from acacia gum · Healthy men and women with plasma cholesterol greater than 5.17 mmol/L (greater than 200 mg/dL) | 17.2 g | 4 weeks | — |
| Combining wheat bran with resistant starch has more beneficial effects on fecal indexes than does wheat bran alone 2004 · WBRS diet · Volunteers with a family history of colorectal cancer; age and sex not reported | 34 g | 3 weeks | — |
| The effect of high-fiber rye bread enriched with nonesterified plant sterols on major serum lipids and apolipoproteins in normocholesterolemic individuals 2012 · Active group, first phase · Healthy normocholesterolemic individuals; age and sex not specified | 9.3 g | 2 weeks | — |
| The effect of high-fiber rye bread enriched with nonesterified plant sterols on major serum lipids and apolipoproteins in normocholesterolemic individuals 2012 · Active group, second phase · Healthy normocholesterolemic individuals; age and sex not specified | 18.6 g | 2 weeks | — |
| Phytoestrogens/insoluble fibers and colonic estrogen receptor β: randomized, double-blind, placebo-controlled study 2013 · active dietary intervention (ADI) · Patients with previous sporadic colonic adenomas scheduled for surveillance colonoscopy | 1.5 g | 60 days | — |
| Whey Protein Combined with Low Dietary Fiber Improves Lipid Profile in Subjects with Abdominal Obesity: A Randomized, Controlled Trial 2019 · WP-HiFi · Adults aged 40 years or older with abdominal obesity | 30 g | 12 weeks | — |
| Diet-Associated Inflammation Modulates Inflammation and WNT Signaling in the Rectal Mucosa, and the Response to Supplementation with Dietary Fiber 2021 · RS and PD · Healthy adults aged 30–80 years; 53% female | 35 g | 50 days | — |
| Sex, Food, and the Gut Microbiota: Disparate Response to Caloric Restriction Diet with Fiber Supplementation in Women and Men 2021 · fiber supplementation group · Overweight participants; age and sex not specified | 10 g | 12 weeks | — |
| The cholesterol-lowering effect of a breakfast cereal containing psyllium fibre 1994 · Psyllium/oats/barley cereal · Men aged 31–69 years (average age 50) with mild hypercholesterolaemia, otherwise healthy and eating a low-saturated-fat diet | 12 g | 6 weeks | — |
| Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults 1994 · L. GG yogurt and rye fiber product · Healthy females aged 20–41 years | 9 g | 4 weeks | — |
| Randomized, double-blinded, placebo-controlled study of effect of wheat bran fiber and calcium on fecal bile acids in patients with resected adenomatous colon polyps 1996 · Low-dose fiber, low-dose calcium group · Adults with a history of resected colon adenomas | 2 g | 39 weeks | — |
| Randomized, double-blinded, placebo-controlled study of effect of wheat bran fiber and calcium on fecal bile acids in patients with resected adenomatous colon polyps 1996 · High-dose fiber, low-dose calcium group · Adults with a history of resected colon adenomas | 13.5 g | 39 weeks | — |
| Randomized, double-blinded, placebo-controlled study of effect of wheat bran fiber and calcium on fecal bile acids in patients with resected adenomatous colon polyps 1996 · Low-dose fiber, high-dose calcium group · Adults with a history of resected colon adenomas | 2 g | 39 weeks | — |
| Randomized, double-blinded, placebo-controlled study of effect of wheat bran fiber and calcium on fecal bile acids in patients with resected adenomatous colon polyps 1996 · High-dose fiber, high-dose calcium group · Adults with a history of resected colon adenomas | 13.5 g | 39 weeks | — |
| A Synergistic Formulation of Plant Extracts Decreases Postprandial Glucose and Insulin Peaks: Results from Two Randomized, Controlled, Cross-Over Studies Using Real-World Meals 2018 · Study 1 IP-B · Healthy men and women aged 18–64 years with BMI 22.99–29.99 kg/m² | 5 g | 1 day | 16 |
| Gastrointestinal microbiome modulator improves glucose tolerance in overweight and obese subjects: A randomized controlled pilot trial 2015 · GIMM · Adults aged 18–70 who were overweight or obese (BMI 25–45 kg/m²) and had fasting blood glucose of 100–200 mg/dL | 8.8 g | 4 weeks | 15 |
| Jaboticaba peel intake improved cognitive performance, inflammatory response, and appetite regulation in healthy adults: a randomized clinical crossover trial 2025 · jaboticaba peel powder (JPP) · Healthy adults; 19 participants completed (8 men and 11 women), average age 27.5 years | 2.4 g | 4 weeks | — |
| Fermentability of an enzymatically modified solubilised potato polysaccharide (SPP) 1998 · 20 g oat bran · Seven healthy volunteers; age and sex not specified | 20 g | 1 day | 7 |
| Fermentability of an enzymatically modified solubilised potato polysaccharide (SPP) 1998 · 20 g wheat bran · Seven healthy volunteers; age and sex not specified | 20 g | 1 day | 7 |
| Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: a double-blind, randomised, placebo-controlled, cross-over trial 2012 · 3 g WBE/d · Healthy adult volunteers; age range and sex not specified | 3 g | 3 weeks | — |